Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hmbox1
|
ENSMUSG00000021972.8 | homeobox containing 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr14_64946712_64946864 | Hmbox1 | 2844 | 0.227539 | -0.41 | 1.2e-03 | Click! |
chr14_64948631_64949819 | Hmbox1 | 407 | 0.688070 | 0.37 | 3.6e-03 | Click! |
chr14_64946906_64947080 | Hmbox1 | 2639 | 0.235649 | -0.31 | 1.7e-02 | Click! |
chr14_64901948_64902099 | Hmbox1 | 1243 | 0.441368 | -0.30 | 2.0e-02 | Click! |
chr14_64947421_64947572 | Hmbox1 | 2136 | 0.263738 | 0.06 | 6.7e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr16_90738322_90739000 | 15.47 |
Mrap |
melanocortin 2 receptor accessory protein |
337 |
0.85 |
chr3_153851643_153852027 | 15.33 |
Asb17os |
ankyrin repeat and SOCS box-containing 17, opposite strand |
566 |
0.59 |
chr11_102360845_102363484 | 14.88 |
Slc4a1 |
solute carrier family 4 (anion exchanger), member 1 |
1540 |
0.24 |
chr3_88501233_88501436 | 11.64 |
Lmna |
lamin A |
1973 |
0.15 |
chr16_44015370_44016774 | 10.98 |
Gramd1c |
GRAM domain containing 1C |
364 |
0.83 |
chr9_24772390_24773199 | 10.04 |
Tbx20 |
T-box 20 |
1490 |
0.39 |
chr6_41700699_41701150 | 9.58 |
Kel |
Kell blood group |
1756 |
0.24 |
chr8_80867565_80868184 | 9.36 |
Gm31105 |
predicted gene, 31105 |
12066 |
0.18 |
chr7_100465236_100467118 | 8.77 |
C2cd3 |
C2 calcium-dependent domain containing 3 |
770 |
0.37 |
chr8_85380167_85381092 | 8.53 |
Mylk3 |
myosin light chain kinase 3 |
349 |
0.83 |
chr3_135827808_135828432 | 8.49 |
Slc39a8 |
solute carrier family 39 (metal ion transporter), member 8 |
2030 |
0.27 |
chr8_105300988_105301570 | 8.37 |
E2f4 |
E2F transcription factor 4 |
2646 |
0.08 |
chr14_76532606_76533942 | 8.36 |
E130202H07Rik |
RIKEN cDNA E130202H07 gene |
6658 |
0.2 |
chr18_35555130_35555680 | 8.27 |
Snhg4 |
small nucleolar RNA host gene 4 |
734 |
0.29 |
chr14_70706940_70707491 | 8.00 |
Xpo7 |
exportin 7 |
820 |
0.57 |
chr2_164772892_164773805 | 7.82 |
Ube2c |
ubiquitin-conjugating enzyme E2C |
3445 |
0.09 |
chrX_10714381_10715702 | 7.72 |
Mid1ip1 |
Mid1 interacting protein 1 (gastrulation specific G12-like (zebrafish)) |
22 |
0.97 |
chr8_84197222_84198671 | 7.72 |
Gm26887 |
predicted gene, 26887 |
279 |
0.72 |
chr3_83026692_83027527 | 7.61 |
Fga |
fibrinogen alpha chain |
894 |
0.5 |
chr6_31125380_31126701 | 7.49 |
5330406M23Rik |
RIKEN cDNA 5330406M23 gene |
15120 |
0.11 |
chr10_115819043_115819440 | 7.47 |
Tspan8 |
tetraspanin 8 |
1957 |
0.43 |
chr15_103250315_103251530 | 7.34 |
Nfe2 |
nuclear factor, erythroid derived 2 |
543 |
0.62 |
chr2_167629085_167629711 | 7.33 |
Ube2v1 |
ubiquitin-conjugating enzyme E2 variant 1 |
2569 |
0.16 |
chr1_58970537_58971332 | 7.32 |
Trak2 |
trafficking protein, kinesin binding 2 |
2495 |
0.2 |
chr5_73189782_73190392 | 7.15 |
Gm42571 |
predicted gene 42571 |
330 |
0.81 |
chr9_42459801_42460026 | 7.10 |
Tbcel |
tubulin folding cofactor E-like |
1548 |
0.36 |
chr5_92127753_92128096 | 7.10 |
Gm24931 |
predicted gene, 24931 |
9641 |
0.12 |
chr13_41020233_41020511 | 7.10 |
Tmem14c |
transmembrane protein 14C |
4080 |
0.14 |
chr8_57513444_57513905 | 7.05 |
Hmgb2 |
high mobility group box 2 |
1126 |
0.33 |
chr10_5803545_5804199 | 6.99 |
Fbxo5 |
F-box protein 5 |
728 |
0.71 |
chr14_63123968_63124478 | 6.97 |
Ctsb |
cathepsin B |
1709 |
0.27 |
chr2_157130956_157131109 | 6.96 |
Samhd1 |
SAM domain and HD domain, 1 |
975 |
0.49 |
chr5_116021804_116022431 | 6.94 |
Prkab1 |
protein kinase, AMP-activated, beta 1 non-catalytic subunit |
471 |
0.73 |
chr1_167392663_167392900 | 6.91 |
Mgst3 |
microsomal glutathione S-transferase 3 |
1060 |
0.47 |
chr19_53186353_53186984 | 6.90 |
Add3 |
adducin 3 (gamma) |
5072 |
0.18 |
chr8_80494890_80495139 | 6.87 |
Gypa |
glycophorin A |
1233 |
0.53 |
chr11_58918085_58918881 | 6.86 |
Btnl10 |
butyrophilin-like 10 |
426 |
0.61 |
chr13_109632540_109633637 | 6.72 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
308 |
0.95 |
chr2_5011626_5012282 | 6.67 |
Mcm10 |
minichromosome maintenance 10 replication initiation factor |
390 |
0.8 |
chr8_120292266_120293650 | 6.63 |
Gse1 |
genetic suppressor element 1, coiled-coil protein |
64502 |
0.09 |
chr17_45591436_45592600 | 6.58 |
Slc29a1 |
solute carrier family 29 (nucleoside transporters), member 1 |
244 |
0.84 |
chr18_84858127_84859558 | 6.53 |
Gm16146 |
predicted gene 16146 |
705 |
0.62 |
chr6_29695942_29696399 | 6.48 |
Tspan33 |
tetraspanin 33 |
1936 |
0.31 |
chr3_153908033_153909893 | 6.47 |
Snord45b |
small nucleolar RNA, C/D box 45B |
1670 |
0.17 |
chr10_58373225_58373745 | 6.43 |
Lims1 |
LIM and senescent cell antigen-like domains 1 |
2031 |
0.32 |
chr4_40851422_40852119 | 6.42 |
Gm25931 |
predicted gene, 25931 |
1368 |
0.21 |
chr3_86798943_86799140 | 6.41 |
Dclk2 |
doublecortin-like kinase 2 |
119 |
0.97 |
chr1_51288641_51290950 | 6.40 |
Cavin2 |
caveolae associated 2 |
669 |
0.72 |
chr6_101271529_101272523 | 6.37 |
9530086O07Rik |
RIKEN cDNA 9530086O07 gene |
16484 |
0.18 |
chr5_88767166_88767376 | 6.32 |
Dck |
deoxycytidine kinase |
2088 |
0.25 |
chr6_97352356_97353426 | 6.31 |
Frmd4b |
FERM domain containing 4B |
1286 |
0.54 |
chr8_88301330_88302008 | 6.25 |
Adcy7 |
adenylate cyclase 7 |
1290 |
0.46 |
chr15_99031345_99031496 | 6.25 |
Tuba1c |
tubulin, alpha 1C |
1099 |
0.31 |
chr8_57319308_57320679 | 6.24 |
Hand2os1 |
Hand2, opposite strand 1 |
63 |
0.94 |
chr15_62039126_62039693 | 6.23 |
Pvt1 |
Pvt1 oncogene |
152 |
0.97 |
chr8_67948178_67948899 | 6.20 |
Psd3 |
pleckstrin and Sec7 domain containing 3 |
3341 |
0.28 |
chr15_57888449_57889538 | 6.11 |
Derl1 |
Der1-like domain family, member 1 |
1401 |
0.45 |
chr11_109470335_109470717 | 6.04 |
Slc16a6 |
solute carrier family 16 (monocarboxylic acid transporters), member 6 |
2162 |
0.18 |
chr15_9074646_9075526 | 5.97 |
Nadk2 |
NAD kinase 2, mitochondrial |
191 |
0.96 |
chr6_136855871_136856717 | 5.93 |
Art4 |
ADP-ribosyltransferase 4 |
1439 |
0.23 |
chr11_90676738_90677124 | 5.90 |
Tom1l1 |
target of myb1-like 1 (chicken) |
10648 |
0.2 |
chr16_91466275_91466861 | 5.88 |
Gm49626 |
predicted gene, 49626 |
1443 |
0.19 |
chr9_118082500_118083548 | 5.87 |
Azi2 |
5-azacytidine induced gene 2 |
23968 |
0.18 |
chr2_163641826_163642055 | 5.83 |
0610039K10Rik |
RIKEN cDNA 0610039K10 gene |
2910 |
0.17 |
chr1_156616903_156618025 | 5.82 |
Abl2 |
v-abl Abelson murine leukemia viral oncogene 2 (arg, Abelson-related gene) |
1541 |
0.36 |
chr9_78104145_78104579 | 5.79 |
Fbxo9 |
f-box protein 9 |
4225 |
0.14 |
chr8_80494157_80494570 | 5.78 |
Gypa |
glycophorin A |
582 |
0.8 |
chr16_77028114_77028411 | 5.78 |
Usp25 |
ubiquitin specific peptidase 25 |
14475 |
0.21 |
chr5_31218023_31218547 | 5.74 |
Ppm1g |
protein phosphatase 1G (formerly 2C), magnesium-dependent, gamma isoform |
2034 |
0.13 |
chr1_160045181_160045638 | 5.73 |
4930523C07Rik |
RIKEN cDNA 4930523C07 gene |
962 |
0.39 |
chr3_138130180_138131364 | 5.70 |
Mttp |
microsomal triglyceride transfer protein |
605 |
0.65 |
chr1_131638462_131638811 | 5.69 |
Ctse |
cathepsin E |
142 |
0.95 |
chr16_38366176_38366327 | 5.65 |
Popdc2 |
popeye domain containing 2 |
2559 |
0.18 |
chr3_152191751_152192635 | 5.61 |
Dnajb4 |
DnaJ heat shock protein family (Hsp40) member B4 |
1652 |
0.26 |
chr1_133798392_133798998 | 5.55 |
Atp2b4 |
ATPase, Ca++ transporting, plasma membrane 4 |
2341 |
0.23 |
chr19_40769301_40769643 | 5.51 |
Cc2d2b |
coiled-coil and C2 domain containing 2B |
4898 |
0.21 |
chr2_35335895_35336943 | 5.45 |
Stom |
stomatin |
557 |
0.68 |
chr15_102460089_102460942 | 5.45 |
Prr13 |
proline rich 13 |
432 |
0.68 |
chr12_91745342_91746056 | 5.44 |
Ston2 |
stonin 2 |
385 |
0.85 |
chr13_51647699_51648388 | 5.42 |
Gm22806 |
predicted gene, 22806 |
156 |
0.94 |
chr10_127749619_127751660 | 5.30 |
Gpr182 |
G protein-coupled receptor 182 |
1093 |
0.28 |
chr12_51828004_51828155 | 5.27 |
Hectd1 |
HECT domain E3 ubiquitin protein ligase 1 |
1239 |
0.47 |
chr5_139733826_139734453 | 5.24 |
Micall2 |
MICAL-like 2 |
1305 |
0.36 |
chr7_27450272_27450472 | 5.19 |
Blvrb |
biliverdin reductase B (flavin reductase (NADPH)) |
2046 |
0.16 |
chr2_121035039_121035972 | 5.18 |
Epb42 |
erythrocyte membrane protein band 4.2 |
1176 |
0.33 |
chr18_65802028_65802182 | 5.16 |
Sec11c |
SEC11 homolog C, signal peptidase complex subunit |
803 |
0.51 |
chr17_46713012_46713341 | 5.15 |
Pex6 |
peroxisomal biogenesis factor 6 |
1700 |
0.19 |
chr13_24420040_24420441 | 5.11 |
Cmah |
cytidine monophospho-N-acetylneuraminic acid hydroxylase |
3016 |
0.19 |
chr2_158306583_158307357 | 5.11 |
Lbp |
lipopolysaccharide binding protein |
358 |
0.8 |
chr4_129462538_129462888 | 5.03 |
Bsdc1 |
BSD domain containing 1 |
877 |
0.4 |
chr4_24646454_24646781 | 5.01 |
Klhl32 |
kelch-like 32 |
28810 |
0.22 |
chr1_172501767_172503923 | 5.01 |
Tagln2 |
transgelin 2 |
1593 |
0.22 |
chr3_131269218_131269951 | 5.00 |
Hadh |
hydroxyacyl-Coenzyme A dehydrogenase |
2440 |
0.24 |
chr2_38164437_38165018 | 4.99 |
Dennd1a |
DENN/MADD domain containing 1A |
1354 |
0.47 |
chr19_17335214_17335760 | 4.95 |
Gcnt1 |
glucosaminyl (N-acetyl) transferase 1, core 2 |
51 |
0.98 |
chr5_90461545_90461920 | 4.95 |
Alb |
albumin |
587 |
0.71 |
chr11_32288387_32289175 | 4.94 |
Hbq1b |
hemoglobin, theta 1B |
1780 |
0.2 |
chr8_123978308_123979538 | 4.93 |
Abcb10 |
ATP-binding cassette, sub-family B (MDR/TAP), member 10 |
4199 |
0.12 |
chr3_60502793_60502944 | 4.93 |
Mbnl1 |
muscleblind like splicing factor 1 |
1590 |
0.46 |
chr12_98268744_98269348 | 4.92 |
Gpr65 |
G-protein coupled receptor 65 |
411 |
0.79 |
chr18_11055272_11055490 | 4.92 |
Gata6 |
GATA binding protein 6 |
343 |
0.89 |
chr5_129006398_129007001 | 4.87 |
Stx2 |
syntaxin 2 |
1724 |
0.37 |
chr7_100860786_100861064 | 4.87 |
Relt |
RELT tumor necrosis factor receptor |
2233 |
0.23 |
chr7_19290671_19291896 | 4.86 |
Rtn2 |
reticulon 2 (Z-band associated protein) |
214 |
0.83 |
chr17_25222989_25223237 | 4.84 |
Unkl |
unkempt family like zinc finger |
334 |
0.75 |
chr9_107975554_107976970 | 4.80 |
Uba7 |
ubiquitin-like modifier activating enzyme 7 |
46 |
0.91 |
chr11_102217551_102219283 | 4.80 |
Hdac5 |
histone deacetylase 5 |
511 |
0.62 |
chr11_121238350_121238986 | 4.78 |
Narf |
nuclear prelamin A recognition factor |
1415 |
0.28 |
chr8_105799077_105799898 | 4.77 |
Ranbp10 |
RAN binding protein 10 |
27718 |
0.08 |
chr2_158145151_158146425 | 4.77 |
Tgm2 |
transglutaminase 2, C polypeptide |
578 |
0.71 |
chr18_12256920_12257106 | 4.77 |
Ankrd29 |
ankyrin repeat domain 29 |
14684 |
0.14 |
chr4_87804582_87805116 | 4.76 |
Mllt3 |
myeloid/lymphoid or mixed-lineage leukemia; translocated to, 3 |
1445 |
0.57 |
chr16_32164334_32164695 | 4.72 |
Nrros |
negative regulator of reactive oxygen species |
943 |
0.44 |
chr18_62176067_62177775 | 4.71 |
Adrb2 |
adrenergic receptor, beta 2 |
3038 |
0.24 |
chr17_71267313_71267689 | 4.70 |
Emilin2 |
elastin microfibril interfacer 2 |
1096 |
0.45 |
chr3_152189105_152190257 | 4.68 |
Dnajb4 |
DnaJ heat shock protein family (Hsp40) member B4 |
4164 |
0.14 |
chr1_51478930_51479199 | 4.67 |
Nabp1 |
nucleic acid binding protein 1 |
639 |
0.71 |
chr2_36198146_36199404 | 4.66 |
Gm13429 |
predicted gene 13429 |
3539 |
0.16 |
chr11_98809138_98809289 | 4.66 |
Casc3 |
cancer susceptibility candidate 3 |
595 |
0.45 |
chr14_32167230_32167769 | 4.65 |
Ncoa4 |
nuclear receptor coactivator 4 |
1378 |
0.28 |
chr1_13588256_13588585 | 4.64 |
Tram1 |
translocating chain-associating membrane protein 1 |
1455 |
0.44 |
chr5_34581849_34582782 | 4.63 |
Gm42867 |
predicted gene 42867 |
7227 |
0.11 |
chr13_59820826_59821264 | 4.63 |
Tut7 |
terminal uridylyl transferase 7 |
1543 |
0.23 |
chr7_17060653_17061482 | 4.62 |
Hif3a |
hypoxia inducible factor 3, alpha subunit |
1317 |
0.27 |
chr16_77027836_77028095 | 4.62 |
Usp25 |
ubiquitin specific peptidase 25 |
14178 |
0.21 |
chr2_119616652_119616909 | 4.61 |
Nusap1 |
nucleolar and spindle associated protein 1 |
1518 |
0.22 |
chr11_31876349_31876576 | 4.61 |
Cpeb4 |
cytoplasmic polyadenylation element binding protein 4 |
3187 |
0.27 |
chr1_33668810_33668964 | 4.59 |
Prim2 |
DNA primase, p58 subunit |
908 |
0.33 |
chr5_103755393_103755691 | 4.59 |
Aff1 |
AF4/FMR2 family, member 1 |
969 |
0.6 |
chr18_64482648_64483016 | 4.58 |
Fech |
ferrochelatase |
3321 |
0.2 |
chr19_32179674_32180543 | 4.55 |
Sgms1 |
sphingomyelin synthase 1 |
16320 |
0.21 |
chr4_138973655_138973849 | 4.52 |
Tmco4 |
transmembrane and coiled-coil domains 4 |
843 |
0.55 |
chr18_80258361_80258974 | 4.52 |
Slc66a2 |
solute carrier family 66 member 2 |
2349 |
0.18 |
chr9_107982030_107984233 | 4.51 |
Gm20661 |
predicted gene 20661 |
38 |
0.54 |
chr11_82746952_82747443 | 4.51 |
Gm11420 |
predicted gene 11420 |
992 |
0.38 |
chr11_58199579_58200256 | 4.50 |
Irgm2 |
immunity-related GTPase family M member 2 |
299 |
0.49 |
chr5_116446483_116447070 | 4.49 |
Srrm4 |
serine/arginine repetitive matrix 4 |
68 |
0.96 |
chr13_37963528_37964564 | 4.48 |
Rreb1 |
ras responsive element binding protein 1 |
17030 |
0.17 |
chr3_60500059_60500210 | 4.48 |
Mbnl1 |
muscleblind like splicing factor 1 |
801 |
0.7 |
chr7_75612178_75613652 | 4.48 |
Akap13 |
A kinase (PRKA) anchor protein 13 |
631 |
0.75 |
chr12_17538399_17538701 | 4.46 |
Odc1 |
ornithine decarboxylase, structural 1 |
6244 |
0.15 |
chr10_69785224_69786670 | 4.46 |
Ank3 |
ankyrin 3, epithelial |
422 |
0.91 |
chr3_83028731_83029005 | 4.45 |
Fga |
fibrinogen alpha chain |
2653 |
0.2 |
chr5_139381758_139382299 | 4.45 |
Gpr146 |
G protein-coupled receptor 146 |
1447 |
0.27 |
chr2_35060883_35061388 | 4.45 |
Hc |
hemolytic complement |
303 |
0.88 |
chr3_104639545_104639873 | 4.44 |
Slc16a1 |
solute carrier family 16 (monocarboxylic acid transporters), member 1 |
1041 |
0.32 |
chr6_49208234_49209239 | 4.44 |
Igf2bp3 |
insulin-like growth factor 2 mRNA binding protein 3 |
5425 |
0.17 |
chr16_36934847_36935880 | 4.43 |
Hcls1 |
hematopoietic cell specific Lyn substrate 1 |
380 |
0.77 |
chr9_70420553_70420960 | 4.42 |
Ccnb2 |
cyclin B2 |
791 |
0.59 |
chr5_115948395_115949019 | 4.41 |
Cit |
citron |
2383 |
0.26 |
chr7_142656274_142657427 | 4.41 |
Igf2 |
insulin-like growth factor 2 |
616 |
0.54 |
chrX_8271051_8272966 | 4.39 |
Slc38a5 |
solute carrier family 38, member 5 |
366 |
0.82 |
chr18_64484316_64484544 | 4.38 |
Fech |
ferrochelatase |
4511 |
0.18 |
chr7_49760410_49760729 | 4.37 |
Htatip2 |
HIV-1 Tat interactive protein 2 |
1416 |
0.46 |
chr8_109779939_109780090 | 4.34 |
Ap1g1 |
adaptor protein complex AP-1, gamma 1 subunit |
1108 |
0.45 |
chr6_135199515_135199935 | 4.34 |
Fam234b |
family with sequence similarity 234, member B |
1313 |
0.27 |
chr17_24426731_24427773 | 4.34 |
Eci1 |
enoyl-Coenzyme A delta isomerase 1 |
261 |
0.8 |
chr15_9078875_9079572 | 4.33 |
Nadk2 |
NAD kinase 2, mitochondrial |
3946 |
0.26 |
chr15_76242501_76243437 | 4.32 |
Parp10 |
poly (ADP-ribose) polymerase family, member 10 |
451 |
0.59 |
chrX_38575712_38576177 | 4.31 |
Cul4b |
cullin 4B |
239 |
0.93 |
chr6_41700162_41700414 | 4.31 |
Kel |
Kell blood group |
1120 |
0.37 |
chr2_173024069_173026002 | 4.29 |
Rbm38 |
RNA binding motif protein 38 |
1985 |
0.21 |
chr1_58955631_58955812 | 4.28 |
Trak2 |
trafficking protein, kinesin binding 2 |
9384 |
0.15 |
chr6_72097601_72098597 | 4.26 |
St3gal5 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 5 |
342 |
0.8 |
chr8_122550130_122550538 | 4.26 |
Piezo1 |
piezo-type mechanosensitive ion channel component 1 |
995 |
0.35 |
chr14_79515651_79516545 | 4.25 |
Elf1 |
E74-like factor 1 |
400 |
0.83 |
chr2_112268023_112268203 | 4.22 |
Slc12a6 |
solute carrier family 12, member 6 |
1294 |
0.28 |
chr6_88897317_88897924 | 4.21 |
Mcm2 |
minichromosome maintenance complex component 2 |
1057 |
0.36 |
chr13_23744307_23745018 | 4.21 |
H3c3 |
H3 clustered histone 3 |
940 |
0.18 |
chr4_86668806_86669103 | 4.20 |
Plin2 |
perilipin 2 |
606 |
0.73 |
chr18_78121610_78122242 | 4.19 |
Slc14a1 |
solute carrier family 14 (urea transporter), member 1 |
1405 |
0.49 |
chr10_128015835_128016219 | 4.19 |
Prim1 |
DNA primase, p49 subunit |
831 |
0.38 |
chr11_58214604_58215588 | 4.18 |
Irgm2 |
immunity-related GTPase family M member 2 |
68 |
0.95 |
chr12_101080889_101081491 | 4.17 |
D130020L05Rik |
RIKEN cDNA D130020L05 gene |
1261 |
0.3 |
chr17_56275991_56276741 | 4.17 |
Ticam1 |
toll-like receptor adaptor molecule 1 |
420 |
0.69 |
chr2_39325776_39326109 | 4.16 |
Vmn2r-ps2 |
vomeronasal 2, receptor, pseudogene 2 |
51836 |
0.11 |
chrX_9254088_9254247 | 4.16 |
Gm14862 |
predicted gene 14862 |
2732 |
0.19 |
chr2_84841249_84841911 | 4.15 |
Slc43a1 |
solute carrier family 43, member 1 |
955 |
0.41 |
chr5_129005766_129006301 | 4.15 |
Stx2 |
syntaxin 2 |
2390 |
0.3 |
chr2_78720365_78720563 | 4.14 |
Gm14463 |
predicted gene 14463 |
63035 |
0.13 |
chr1_82647929_82648309 | 4.13 |
n-R5s213 |
nuclear encoded rRNA 5S 213 |
13106 |
0.16 |
chr9_83253415_83254213 | 4.13 |
Gm27216 |
predicted gene 27216 |
208 |
0.95 |
chr11_60933539_60933746 | 4.12 |
Map2k3 |
mitogen-activated protein kinase kinase 3 |
1576 |
0.25 |
chr14_37133439_37133904 | 4.10 |
Ghitm |
growth hormone inducible transmembrane protein |
1468 |
0.35 |
chr5_107960604_107960786 | 4.09 |
Dipk1a |
divergent protein kinase domain 1A |
12303 |
0.13 |
chr19_5724785_5726881 | 4.08 |
Ehbp1l1 |
EH domain binding protein 1-like 1 |
437 |
0.54 |
chr7_109602034_109602191 | 4.07 |
Denn2b |
DENN domain containing 2B |
553 |
0.75 |
chr14_46831364_46831682 | 4.07 |
Gm10101 |
predicted gene 10101 |
504 |
0.44 |
chr1_128358474_128359134 | 4.05 |
Mcm6 |
minichromosome maintenance complex component 6 |
843 |
0.58 |
chr8_109870019_109870716 | 4.04 |
Phlpp2 |
PH domain and leucine rich repeat protein phosphatase 2 |
1756 |
0.22 |
chr4_87803538_87803927 | 4.02 |
Mllt3 |
myeloid/lymphoid or mixed-lineage leukemia; translocated to, 3 |
2562 |
0.41 |
chr2_130275476_130275713 | 4.02 |
Snord110 |
small nucleolar RNA, C/D box 110 |
88 |
0.61 |
chr3_100921543_100921984 | 4.00 |
Trim45 |
tripartite motif-containing 45 |
439 |
0.82 |
chr5_31685790_31686074 | 3.99 |
Rbks |
ribokinase |
161 |
0.93 |
chr18_3280827_3281518 | 3.98 |
Crem |
cAMP responsive element modulator |
40 |
0.98 |
chr11_54026747_54027441 | 3.96 |
Slc22a4 |
solute carrier family 22 (organic cation transporter), member 4 |
858 |
0.54 |
chr1_135837715_135838209 | 3.95 |
Tnnt2 |
troponin T2, cardiac |
1549 |
0.29 |
chr10_58393012_58393220 | 3.95 |
Lims1 |
LIM and senescent cell antigen-like domains 1 |
1257 |
0.48 |
chr7_141505665_141505980 | 3.95 |
Gm45416 |
predicted gene 45416 |
12781 |
0.07 |
chr3_102165384_102165916 | 3.94 |
Vangl1 |
VANGL planar cell polarity 1 |
290 |
0.87 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.8 | 14.5 | GO:0048769 | sarcomerogenesis(GO:0048769) |
3.9 | 11.6 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
3.2 | 9.7 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
3.2 | 9.5 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
2.7 | 2.7 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
2.6 | 13.0 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
2.5 | 7.6 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
2.4 | 7.3 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
2.2 | 6.6 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
2.2 | 8.6 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
2.2 | 12.9 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
2.1 | 6.3 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
2.1 | 6.2 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
2.0 | 2.0 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
2.0 | 12.2 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
1.8 | 5.5 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
1.8 | 7.2 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
1.7 | 8.5 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
1.7 | 5.0 | GO:0042167 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
1.6 | 1.6 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
1.5 | 7.7 | GO:0071918 | urea transmembrane transport(GO:0071918) |
1.5 | 4.6 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
1.5 | 4.5 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
1.5 | 7.4 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
1.5 | 2.9 | GO:0008228 | opsonization(GO:0008228) |
1.4 | 4.3 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
1.4 | 5.7 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
1.4 | 2.8 | GO:0042908 | xenobiotic transport(GO:0042908) |
1.4 | 4.2 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
1.4 | 4.2 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
1.4 | 2.7 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
1.4 | 5.5 | GO:0003175 | tricuspid valve development(GO:0003175) |
1.3 | 4.0 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
1.3 | 4.0 | GO:0006203 | dGTP catabolic process(GO:0006203) |
1.3 | 5.2 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
1.3 | 5.2 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
1.3 | 5.1 | GO:0070836 | caveola assembly(GO:0070836) |
1.3 | 8.9 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
1.3 | 6.4 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
1.3 | 3.8 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
1.2 | 5.0 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070432) |
1.2 | 3.7 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
1.2 | 3.7 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
1.2 | 11.0 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
1.2 | 3.7 | GO:0061511 | centriole elongation(GO:0061511) |
1.2 | 4.9 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
1.2 | 4.9 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
1.2 | 3.6 | GO:0061010 | gall bladder development(GO:0061010) |
1.2 | 6.0 | GO:0090527 | actin filament reorganization(GO:0090527) |
1.2 | 1.2 | GO:0033668 | negative regulation by symbiont of host apoptotic process(GO:0033668) modulation of programmed cell death in other organism(GO:0044531) modulation of apoptotic process in other organism(GO:0044532) modulation by symbiont of host programmed cell death(GO:0052040) negative regulation by symbiont of host programmed cell death(GO:0052041) modulation by symbiont of host apoptotic process(GO:0052150) modulation of programmed cell death in other organism involved in symbiotic interaction(GO:0052248) modulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052433) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
1.2 | 3.6 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
1.2 | 3.5 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
1.1 | 5.7 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
1.1 | 28.5 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
1.1 | 4.6 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
1.1 | 9.1 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
1.1 | 3.4 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
1.1 | 3.3 | GO:0071316 | cellular response to nicotine(GO:0071316) |
1.1 | 3.3 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
1.1 | 4.4 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
1.1 | 4.4 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
1.1 | 2.2 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
1.1 | 3.3 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
1.1 | 3.2 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
1.1 | 4.3 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
1.1 | 4.2 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
1.1 | 4.2 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
1.0 | 5.2 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
1.0 | 9.4 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
1.0 | 3.1 | GO:1900045 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
1.0 | 9.2 | GO:0070269 | pyroptosis(GO:0070269) |
1.0 | 9.2 | GO:0016540 | protein autoprocessing(GO:0016540) |
1.0 | 3.1 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
1.0 | 3.0 | GO:2001271 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
1.0 | 3.0 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
1.0 | 5.0 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
1.0 | 3.0 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
1.0 | 3.0 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
1.0 | 5.9 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
1.0 | 2.9 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
1.0 | 1.0 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
1.0 | 4.8 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
0.9 | 4.7 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.9 | 3.7 | GO:0006848 | pyruvate transport(GO:0006848) |
0.9 | 1.8 | GO:0050904 | diapedesis(GO:0050904) |
0.9 | 3.7 | GO:1905206 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.9 | 3.7 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.9 | 2.7 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.9 | 1.8 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.9 | 0.9 | GO:0007127 | meiosis I(GO:0007127) |
0.9 | 0.9 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.9 | 3.6 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.9 | 3.5 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.9 | 1.8 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.9 | 5.2 | GO:0015684 | ferrous iron transport(GO:0015684) |
0.9 | 3.5 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.9 | 2.6 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
0.9 | 12.9 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.9 | 7.8 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.9 | 3.4 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.9 | 5.1 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.9 | 2.6 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.9 | 0.9 | GO:0070295 | renal water absorption(GO:0070295) |
0.9 | 1.7 | GO:0071733 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
0.8 | 6.8 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.8 | 3.4 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.8 | 4.2 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.8 | 2.5 | GO:0010911 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.8 | 0.8 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
0.8 | 5.0 | GO:0033572 | transferrin transport(GO:0033572) |
0.8 | 1.7 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.8 | 4.2 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.8 | 5.8 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.8 | 2.5 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
0.8 | 2.5 | GO:0046618 | drug export(GO:0046618) |
0.8 | 7.4 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
0.8 | 3.3 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.8 | 2.4 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.8 | 4.8 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.8 | 0.8 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.8 | 1.6 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.8 | 0.8 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.8 | 0.8 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.8 | 1.6 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.8 | 14.1 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.8 | 2.3 | GO:0072125 | negative regulation of glomerular mesangial cell proliferation(GO:0072125) negative regulation of glomerulus development(GO:0090194) |
0.8 | 5.4 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.8 | 1.5 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.8 | 3.8 | GO:0015879 | carnitine transport(GO:0015879) |
0.8 | 2.3 | GO:0010649 | regulation of cell communication by electrical coupling(GO:0010649) |
0.8 | 2.3 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.8 | 2.3 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.7 | 3.0 | GO:1901524 | regulation of macromitophagy(GO:1901524) negative regulation of macromitophagy(GO:1901525) |
0.7 | 3.0 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.7 | 1.5 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.7 | 2.2 | GO:0006227 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.7 | 2.2 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.7 | 1.5 | GO:0072718 | response to cisplatin(GO:0072718) |
0.7 | 3.6 | GO:0055015 | ventricular cardiac muscle cell development(GO:0055015) |
0.7 | 1.4 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.7 | 3.6 | GO:0030578 | PML body organization(GO:0030578) |
0.7 | 0.7 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
0.7 | 3.6 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.7 | 1.4 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.7 | 6.4 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.7 | 2.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.7 | 2.8 | GO:0009597 | detection of virus(GO:0009597) |
0.7 | 2.1 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.7 | 2.8 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.7 | 1.4 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.7 | 2.8 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.7 | 4.2 | GO:1902222 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.7 | 6.9 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.7 | 3.4 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.7 | 0.7 | GO:0042023 | DNA endoreduplication(GO:0042023) |
0.7 | 4.0 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.7 | 2.0 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.7 | 4.0 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.7 | 2.7 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
0.7 | 1.3 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.7 | 2.7 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.7 | 10.0 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.7 | 1.3 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.7 | 2.0 | GO:0000087 | mitotic M phase(GO:0000087) |
0.7 | 1.3 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.7 | 11.2 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.7 | 3.3 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.7 | 2.0 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.7 | 3.9 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.6 | 2.6 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.6 | 2.6 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) positive regulation of centrosome cycle(GO:0046607) |
0.6 | 3.8 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.6 | 1.9 | GO:0006188 | IMP biosynthetic process(GO:0006188) |
0.6 | 3.2 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.6 | 0.6 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.6 | 1.9 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.6 | 12.1 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.6 | 3.2 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.6 | 2.5 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.6 | 3.2 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.6 | 1.3 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.6 | 0.6 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.6 | 1.9 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.6 | 7.5 | GO:0015858 | nucleoside transport(GO:0015858) |
0.6 | 2.5 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.6 | 7.5 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.6 | 4.9 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.6 | 1.8 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.6 | 1.2 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.6 | 1.8 | GO:2000836 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.6 | 3.6 | GO:0051639 | actin filament network formation(GO:0051639) |
0.6 | 1.2 | GO:0042117 | monocyte activation(GO:0042117) |
0.6 | 1.8 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.6 | 3.6 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.6 | 1.2 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.6 | 1.8 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.6 | 5.4 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.6 | 1.8 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.6 | 3.0 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.6 | 1.8 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.6 | 6.0 | GO:2000257 | regulation of protein activation cascade(GO:2000257) |
0.6 | 1.8 | GO:0006562 | proline catabolic process(GO:0006562) |
0.6 | 1.8 | GO:0072095 | regulation of branch elongation involved in ureteric bud branching(GO:0072095) |
0.6 | 4.1 | GO:0034435 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.6 | 2.9 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.6 | 0.6 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.6 | 0.6 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.6 | 4.7 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.6 | 3.5 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.6 | 0.6 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.6 | 6.3 | GO:0051383 | kinetochore organization(GO:0051383) |
0.6 | 2.9 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.6 | 1.1 | GO:0043090 | amino acid import(GO:0043090) |
0.6 | 3.4 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
0.6 | 1.7 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.6 | 1.7 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.6 | 2.3 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.6 | 4.0 | GO:0002024 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.6 | 11.9 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.6 | 1.7 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
0.6 | 1.7 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.6 | 1.1 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.6 | 4.4 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.6 | 1.7 | GO:0046066 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
0.6 | 1.1 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.5 | 1.1 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.5 | 0.5 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
0.5 | 1.1 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.5 | 3.3 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.5 | 1.6 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.5 | 1.6 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.5 | 1.6 | GO:0060058 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.5 | 2.7 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.5 | 1.6 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
0.5 | 1.1 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.5 | 2.1 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.5 | 1.6 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.5 | 1.1 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.5 | 0.5 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.5 | 1.6 | GO:2000065 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
0.5 | 0.5 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.5 | 0.5 | GO:0044793 | negative regulation by host of viral process(GO:0044793) |
0.5 | 0.5 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.5 | 3.1 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.5 | 0.5 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.5 | 1.6 | GO:0001805 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
0.5 | 2.1 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.5 | 1.5 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.5 | 3.6 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.5 | 1.5 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.5 | 2.1 | GO:0072711 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
0.5 | 1.0 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.5 | 0.5 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.5 | 2.6 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
0.5 | 1.5 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.5 | 2.0 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.5 | 1.0 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.5 | 3.0 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.5 | 4.0 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.5 | 1.5 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.5 | 1.0 | GO:0019661 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.5 | 0.5 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.5 | 3.5 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.5 | 1.5 | GO:1904193 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
0.5 | 0.5 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.5 | 1.5 | GO:0070268 | cornification(GO:0070268) |
0.5 | 5.0 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.5 | 1.5 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.5 | 2.0 | GO:0007144 | female meiosis I(GO:0007144) |
0.5 | 2.0 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.5 | 1.0 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.5 | 0.5 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.5 | 2.0 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.5 | 1.0 | GO:0090114 | COPII-coated vesicle budding(GO:0090114) |
0.5 | 1.0 | GO:0030240 | skeletal myofibril assembly(GO:0014866) skeletal muscle thin filament assembly(GO:0030240) |
0.5 | 1.5 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.5 | 1.5 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.5 | 3.4 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.5 | 1.9 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.5 | 0.5 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.5 | 1.4 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.5 | 2.9 | GO:0060613 | fat pad development(GO:0060613) |
0.5 | 1.4 | GO:0048478 | replication fork protection(GO:0048478) |
0.5 | 2.9 | GO:0035826 | rubidium ion transport(GO:0035826) |
0.5 | 1.9 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.5 | 2.4 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.5 | 3.3 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.5 | 1.4 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.5 | 1.0 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.5 | 2.9 | GO:0071267 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.5 | 1.0 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.5 | 3.8 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.5 | 0.5 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.5 | 0.9 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.5 | 0.9 | GO:2000338 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
0.5 | 1.4 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.5 | 0.9 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.5 | 16.9 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.5 | 3.8 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.5 | 0.5 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.5 | 4.7 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.5 | 2.8 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.5 | 0.5 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.5 | 0.5 | GO:1903660 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.5 | 2.3 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.5 | 6.0 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.5 | 0.5 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.5 | 1.4 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.5 | 1.4 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.5 | 0.5 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.5 | 6.4 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.5 | 2.7 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.5 | 1.4 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.5 | 2.3 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.5 | 2.7 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.5 | 1.8 | GO:0090148 | membrane fission(GO:0090148) |
0.5 | 4.1 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.4 | 1.8 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.4 | 8.1 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.4 | 5.4 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.4 | 0.4 | GO:0035404 | histone-serine phosphorylation(GO:0035404) |
0.4 | 0.9 | GO:0072350 | tricarboxylic acid metabolic process(GO:0072350) |
0.4 | 0.4 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.4 | 0.9 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.4 | 1.3 | GO:0034633 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.4 | 0.9 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.4 | 1.3 | GO:0032252 | secretory granule localization(GO:0032252) |
0.4 | 11.9 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.4 | 3.5 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.4 | 0.9 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.4 | 2.2 | GO:0072366 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.4 | 3.5 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.4 | 0.9 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.4 | 10.5 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.4 | 1.3 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.4 | 3.9 | GO:0031269 | pseudopodium assembly(GO:0031269) |
0.4 | 1.7 | GO:0061083 | regulation of protein refolding(GO:0061083) |
0.4 | 9.1 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.4 | 3.5 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.4 | 3.5 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.4 | 4.3 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.4 | 2.2 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.4 | 2.6 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.4 | 3.9 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.4 | 0.4 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.4 | 2.6 | GO:0051451 | myoblast migration(GO:0051451) |
0.4 | 6.0 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.4 | 2.1 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.4 | 1.3 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.4 | 3.8 | GO:1901889 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of cell junction assembly(GO:1901889) |
0.4 | 0.8 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.4 | 2.1 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.4 | 1.3 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.4 | 0.8 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.4 | 1.3 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.4 | 1.7 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.4 | 1.3 | GO:0016237 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
0.4 | 0.8 | GO:0043558 | regulation of translational initiation in response to stress(GO:0043558) |
0.4 | 0.4 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.4 | 0.4 | GO:2000615 | regulation of histone H3-K9 acetylation(GO:2000615) |
0.4 | 0.4 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.4 | 0.8 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.4 | 1.7 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.4 | 0.4 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.4 | 1.7 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.4 | 1.6 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.4 | 7.8 | GO:0014823 | response to activity(GO:0014823) |
0.4 | 0.8 | GO:0014721 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.4 | 1.2 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.4 | 3.7 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.4 | 0.8 | GO:0036394 | amylase secretion(GO:0036394) |
0.4 | 1.2 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.4 | 0.4 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.4 | 1.6 | GO:0042559 | pteridine-containing compound biosynthetic process(GO:0042559) |
0.4 | 1.6 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.4 | 1.6 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.4 | 1.2 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.4 | 1.2 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.4 | 4.0 | GO:0035384 | thioester biosynthetic process(GO:0035384) acyl-CoA biosynthetic process(GO:0071616) |
0.4 | 1.2 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
0.4 | 2.4 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
0.4 | 1.6 | GO:0051697 | protein delipidation(GO:0051697) |
0.4 | 1.2 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.4 | 2.4 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.4 | 0.4 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.4 | 1.6 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.4 | 0.8 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.4 | 1.2 | GO:0010988 | regulation of low-density lipoprotein particle clearance(GO:0010988) |
0.4 | 1.2 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.4 | 2.0 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.4 | 1.2 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.4 | 2.7 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.4 | 1.6 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
0.4 | 3.9 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.4 | 1.2 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.4 | 1.2 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.4 | 1.2 | GO:0044838 | cell quiescence(GO:0044838) |
0.4 | 2.3 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.4 | 1.2 | GO:0051029 | rRNA export from nucleus(GO:0006407) rRNA transport(GO:0051029) |
0.4 | 0.4 | GO:0050665 | hydrogen peroxide biosynthetic process(GO:0050665) |
0.4 | 3.1 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.4 | 5.0 | GO:0006465 | signal peptide processing(GO:0006465) |
0.4 | 1.1 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.4 | 1.9 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.4 | 1.5 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.4 | 4.6 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.4 | 0.4 | GO:0016114 | terpenoid biosynthetic process(GO:0016114) |
0.4 | 0.8 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.4 | 0.4 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.4 | 1.9 | GO:0016266 | O-glycan processing(GO:0016266) |
0.4 | 0.4 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.4 | 0.4 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.4 | 0.8 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.4 | 1.5 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.4 | 1.1 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.4 | 0.7 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.4 | 1.1 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.4 | 7.8 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.4 | 10.4 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.4 | 0.4 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.4 | 0.4 | GO:0045357 | interferon-beta biosynthetic process(GO:0045350) regulation of interferon-beta biosynthetic process(GO:0045357) |
0.4 | 3.3 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.4 | 0.7 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.4 | 0.7 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.4 | 3.3 | GO:0045624 | positive regulation of T-helper cell differentiation(GO:0045624) |
0.4 | 1.1 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.4 | 2.9 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
0.4 | 5.4 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.4 | 0.4 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.4 | 12.6 | GO:0009060 | aerobic respiration(GO:0009060) |
0.4 | 1.4 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.4 | 0.4 | GO:1901859 | negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
0.4 | 0.7 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.4 | 0.4 | GO:1904468 | negative regulation of tumor necrosis factor secretion(GO:1904468) |
0.4 | 0.4 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.4 | 3.5 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.4 | 2.1 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.4 | 0.7 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.4 | 1.1 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.3 | 6.3 | GO:0030488 | tRNA methylation(GO:0030488) |
0.3 | 5.6 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.3 | 1.0 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.3 | 1.0 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.3 | 1.7 | GO:0009074 | tryptophan catabolic process(GO:0006569) aromatic amino acid family catabolic process(GO:0009074) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.3 | 5.5 | GO:0051193 | regulation of cofactor metabolic process(GO:0051193) |
0.3 | 2.4 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
0.3 | 0.3 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.3 | 0.7 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.3 | 0.3 | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.3 | 1.0 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
0.3 | 1.4 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.3 | 1.4 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.3 | 0.7 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.3 | 0.3 | GO:0042762 | regulation of sulfur metabolic process(GO:0042762) |
0.3 | 1.0 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.3 | 6.4 | GO:0016180 | snRNA processing(GO:0016180) |
0.3 | 2.7 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.3 | 3.0 | GO:0019985 | translesion synthesis(GO:0019985) |
0.3 | 0.7 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.3 | 2.7 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.3 | 1.7 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.3 | 1.0 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.3 | 1.7 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.3 | 1.7 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.3 | 1.3 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
0.3 | 1.3 | GO:0051031 | tRNA transport(GO:0051031) |
0.3 | 0.3 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.3 | 0.7 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.3 | 1.3 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.3 | 3.0 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.3 | 1.3 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.3 | 1.6 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.3 | 0.7 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.3 | 1.3 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.3 | 0.7 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.3 | 8.5 | GO:0044784 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) metaphase/anaphase transition of cell cycle(GO:0044784) |
0.3 | 1.0 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.3 | 0.6 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.3 | 3.6 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.3 | 17.8 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.3 | 0.6 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.3 | 0.6 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.3 | 0.6 | GO:0060416 | response to growth hormone(GO:0060416) |
0.3 | 3.5 | GO:0006301 | postreplication repair(GO:0006301) |
0.3 | 2.2 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.3 | 2.6 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.3 | 0.6 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.3 | 3.8 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.3 | 5.4 | GO:0046348 | amino sugar catabolic process(GO:0046348) |
0.3 | 2.2 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.3 | 0.6 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.3 | 1.0 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.3 | 0.6 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.3 | 1.3 | GO:0048254 | snoRNA localization(GO:0048254) |
0.3 | 1.6 | GO:0060426 | lung vasculature development(GO:0060426) |
0.3 | 2.9 | GO:0042026 | protein refolding(GO:0042026) |
0.3 | 0.3 | GO:0016093 | polyprenol metabolic process(GO:0016093) |
0.3 | 1.0 | GO:0015671 | oxygen transport(GO:0015671) |
0.3 | 0.3 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.3 | 5.7 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.3 | 1.3 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.3 | 0.6 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.3 | 6.3 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.3 | 0.9 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.3 | 2.5 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.3 | 2.2 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.3 | 10.1 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.3 | 3.1 | GO:0015816 | glycine transport(GO:0015816) |
0.3 | 2.5 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.3 | 1.6 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.3 | 0.9 | GO:0019042 | viral latency(GO:0019042) |
0.3 | 0.9 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.3 | 0.6 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.3 | 0.6 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.3 | 0.3 | GO:0031947 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
0.3 | 0.6 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.3 | 0.6 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.3 | 0.9 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.3 | 0.6 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.3 | 1.5 | GO:0032607 | interferon-alpha production(GO:0032607) |
0.3 | 4.9 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.3 | 0.9 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.3 | 0.9 | GO:0048102 | autophagic cell death(GO:0048102) |
0.3 | 0.6 | GO:0071027 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.3 | 0.3 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
0.3 | 2.4 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.3 | 0.6 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.3 | 0.6 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.3 | 0.9 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.3 | 1.2 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.3 | 0.9 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.3 | 2.7 | GO:0006415 | translational termination(GO:0006415) |
0.3 | 0.3 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.3 | 2.1 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.3 | 1.2 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.3 | 0.9 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.3 | 0.3 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.3 | 0.6 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.3 | 2.4 | GO:0007097 | nuclear migration(GO:0007097) |
0.3 | 3.6 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.3 | 2.1 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.3 | 0.6 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.3 | 0.3 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.3 | 0.6 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.3 | 0.3 | GO:0036258 | multivesicular body assembly(GO:0036258) |
0.3 | 1.2 | GO:0006265 | DNA topological change(GO:0006265) |
0.3 | 0.6 | GO:0035947 | regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) |
0.3 | 1.5 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.3 | 12.3 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.3 | 0.9 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.3 | 0.9 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.3 | 4.1 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.3 | 2.9 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.3 | 1.2 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.3 | 0.6 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.3 | 0.3 | GO:0002740 | negative regulation of cytokine secretion involved in immune response(GO:0002740) |
0.3 | 0.9 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.3 | 0.3 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
0.3 | 0.9 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.3 | 0.9 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.3 | 0.9 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.3 | 1.2 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.3 | 0.6 | GO:0042701 | progesterone secretion(GO:0042701) |
0.3 | 0.6 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.3 | 2.0 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.3 | 1.7 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.3 | 3.4 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.3 | 2.0 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.3 | 1.7 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.3 | 0.9 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.3 | 2.0 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.3 | 0.3 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.3 | 0.8 | GO:0000467 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.3 | 2.5 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.3 | 1.4 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.3 | 0.6 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.3 | 1.4 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.3 | 0.8 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.3 | 1.1 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.3 | 0.6 | GO:0006983 | ER overload response(GO:0006983) |
0.3 | 1.4 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.3 | 1.7 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.3 | 0.3 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
0.3 | 0.8 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.3 | 0.6 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.3 | 1.9 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) |
0.3 | 0.3 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
0.3 | 6.1 | GO:0065002 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
0.3 | 0.8 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.3 | 0.8 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.3 | 3.6 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.3 | 3.6 | GO:0010447 | response to acidic pH(GO:0010447) |
0.3 | 0.3 | GO:2000553 | regulation of T-helper 2 cell cytokine production(GO:2000551) positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
0.3 | 1.6 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.3 | 1.4 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.3 | 1.4 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.3 | 0.5 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.3 | 0.3 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.3 | 1.1 | GO:0032367 | intracellular cholesterol transport(GO:0032367) |
0.3 | 1.6 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.3 | 4.1 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.3 | 3.3 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.3 | 0.3 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.3 | 1.4 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.3 | 0.8 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) |
0.3 | 0.5 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
0.3 | 2.2 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.3 | 0.5 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.3 | 3.2 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.3 | 2.7 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.3 | 1.6 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.3 | 0.5 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.3 | 1.3 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.3 | 1.6 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.3 | 0.3 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.3 | 0.3 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.3 | 0.5 | GO:0030638 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.3 | 0.8 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.3 | 2.6 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.3 | 1.6 | GO:0006560 | proline metabolic process(GO:0006560) |
0.3 | 1.0 | GO:0039529 | RIG-I signaling pathway(GO:0039529) |
0.3 | 0.8 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.3 | 0.3 | GO:0042525 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.3 | 10.4 | GO:0045576 | mast cell activation(GO:0045576) |
0.3 | 1.3 | GO:0080009 | mRNA methylation(GO:0080009) |
0.3 | 1.3 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.3 | 2.1 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.3 | 0.5 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.3 | 0.5 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.3 | 0.5 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.3 | 0.8 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.3 | 2.3 | GO:0046697 | decidualization(GO:0046697) |
0.3 | 1.5 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.3 | 2.0 | GO:0034063 | stress granule assembly(GO:0034063) |
0.3 | 0.5 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.3 | 1.3 | GO:1904970 | brush border assembly(GO:1904970) |
0.3 | 2.8 | GO:0090224 | regulation of mitotic spindle organization(GO:0060236) regulation of spindle organization(GO:0090224) |
0.3 | 0.3 | GO:0045622 | regulation of T-helper cell differentiation(GO:0045622) |
0.3 | 1.5 | GO:0070572 | positive regulation of neuron projection regeneration(GO:0070572) |
0.3 | 1.0 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.3 | 0.5 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.3 | 3.3 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.3 | 10.6 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.3 | 6.8 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
0.3 | 1.0 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.3 | 0.8 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.3 | 0.8 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.3 | 0.3 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.2 | 0.7 | GO:0003093 | regulation of glomerular filtration(GO:0003093) |
0.2 | 0.5 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.2 | 0.7 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.2 | 3.2 | GO:0000154 | rRNA modification(GO:0000154) |
0.2 | 0.7 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.2 | 2.7 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.2 | 1.0 | GO:0036124 | histone H3-K9 trimethylation(GO:0036124) |
0.2 | 0.2 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.2 | 1.2 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.2 | 0.7 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.2 | 0.2 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.2 | 1.0 | GO:0035247 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine omega-N-methylation(GO:0035247) |
0.2 | 1.2 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.2 | 3.6 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.2 | 0.2 | GO:0030852 | regulation of granulocyte differentiation(GO:0030852) |
0.2 | 1.7 | GO:1904152 | regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
0.2 | 0.7 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.2 | 0.7 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.2 | 1.7 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.2 | 1.4 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.2 | 0.2 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.2 | 1.2 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.2 | 4.8 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.2 | 0.5 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.2 | 0.2 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.2 | 2.6 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.2 | 0.7 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.2 | 0.5 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.2 | 0.7 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.2 | 1.2 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.2 | 0.2 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.2 | 0.5 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.2 | 0.5 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.2 | 1.4 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.2 | 1.2 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.2 | 0.2 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.2 | 1.4 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.2 | 1.2 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.2 | 0.7 | GO:0000012 | single strand break repair(GO:0000012) |
0.2 | 0.2 | GO:2000637 | positive regulation of posttranscriptional gene silencing(GO:0060148) positive regulation of gene silencing by miRNA(GO:2000637) |
0.2 | 1.6 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.2 | 0.9 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.2 | 0.9 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.2 | 0.5 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.2 | 1.1 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.2 | 0.5 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.2 | 7.6 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.2 | 0.7 | GO:0051256 | mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
0.2 | 1.6 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.2 | 4.7 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.2 | 0.9 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.2 | 0.4 | GO:0015809 | arginine transport(GO:0015809) |
0.2 | 7.8 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.2 | 0.7 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.2 | 7.6 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.2 | 2.4 | GO:0061756 | leukocyte tethering or rolling(GO:0050901) leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.2 | 1.5 | GO:0043470 | regulation of carbohydrate catabolic process(GO:0043470) regulation of cellular carbohydrate catabolic process(GO:0043471) |
0.2 | 2.4 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.2 | 0.2 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.2 | 0.9 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.2 | 2.4 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.2 | 0.4 | GO:0009804 | coumarin metabolic process(GO:0009804) |
0.2 | 2.2 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.2 | 0.7 | GO:0015074 | DNA integration(GO:0015074) |
0.2 | 1.1 | GO:0010596 | negative regulation of endothelial cell migration(GO:0010596) |
0.2 | 2.0 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.2 | 1.5 | GO:0043248 | proteasome assembly(GO:0043248) |
0.2 | 1.3 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.2 | 0.4 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.2 | 0.4 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.2 | 0.4 | GO:0090671 | RNA localization to Cajal body(GO:0090670) telomerase RNA localization to Cajal body(GO:0090671) telomerase RNA localization(GO:0090672) regulation of telomerase RNA localization to Cajal body(GO:1904872) positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
0.2 | 0.6 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.2 | 11.2 | GO:0007030 | Golgi organization(GO:0007030) |
0.2 | 0.6 | GO:0071347 | cellular response to interleukin-1(GO:0071347) |
0.2 | 0.9 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.2 | 0.4 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.2 | 1.1 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.2 | 1.7 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.2 | 1.1 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) regulation of RNA export from nucleus(GO:0046831) |
0.2 | 0.2 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.2 | 0.4 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.2 | 0.2 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.2 | 0.2 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.2 | 0.6 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.2 | 0.4 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.2 | 0.2 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
0.2 | 0.2 | GO:1990542 | mitochondrial transmembrane transport(GO:1990542) |
0.2 | 0.6 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.2 | 2.2 | GO:0030261 | chromosome condensation(GO:0030261) |
0.2 | 0.2 | GO:0019682 | glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
0.2 | 0.4 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.2 | 0.8 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.2 | 1.6 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.2 | 1.4 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.2 | 0.8 | GO:0016556 | mRNA modification(GO:0016556) |
0.2 | 0.8 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.2 | 1.2 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.2 | 1.8 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.2 | 0.6 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.2 | 0.8 | GO:0010744 | positive regulation of macrophage derived foam cell differentiation(GO:0010744) |
0.2 | 0.4 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.2 | 1.2 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.2 | 0.2 | GO:0035907 | dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
0.2 | 1.0 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.2 | 0.2 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.2 | 0.2 | GO:0009070 | serine family amino acid biosynthetic process(GO:0009070) |
0.2 | 1.2 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.2 | 0.8 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.2 | 0.4 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.2 | 0.2 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.2 | 0.6 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.2 | 7.2 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.2 | 0.6 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.2 | 0.4 | GO:0033700 | phospholipid efflux(GO:0033700) |
0.2 | 0.4 | GO:1902075 | cellular response to salt(GO:1902075) |
0.2 | 0.4 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.2 | 1.2 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.2 | 0.8 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.2 | 3.3 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.2 | 0.2 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.2 | 0.2 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.2 | 0.6 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.2 | 3.4 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.2 | 1.3 | GO:0032620 | interleukin-17 production(GO:0032620) |
0.2 | 0.6 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.2 | 0.9 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.2 | 0.6 | GO:0060526 | prostate glandular acinus development(GO:0060525) prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.2 | 0.6 | GO:0051304 | chromosome separation(GO:0051304) |
0.2 | 0.8 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.2 | 0.9 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.2 | 0.9 | GO:0055094 | response to lipoprotein particle(GO:0055094) |
0.2 | 0.7 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.2 | 1.5 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.2 | 2.6 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.2 | 0.7 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.2 | 1.3 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.2 | 0.9 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.2 | 0.9 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.2 | 0.2 | GO:0032831 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.2 | 0.5 | GO:0032667 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
0.2 | 0.9 | GO:0009249 | protein lipoylation(GO:0009249) |
0.2 | 0.5 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.2 | 0.2 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.2 | 0.4 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.2 | 0.5 | GO:0010586 | miRNA metabolic process(GO:0010586) |
0.2 | 0.2 | GO:0032070 | regulation of deoxyribonuclease activity(GO:0032070) regulation of endodeoxyribonuclease activity(GO:0032071) |
0.2 | 1.3 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.2 | 3.6 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.2 | 4.5 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.2 | 0.4 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.2 | 0.7 | GO:0018904 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
0.2 | 1.2 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.2 | 0.2 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.2 | 0.5 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.2 | 0.5 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.2 | 0.7 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.2 | 1.6 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.2 | 0.4 | GO:0015886 | heme transport(GO:0015886) |
0.2 | 1.1 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.2 | 0.9 | GO:0060177 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
0.2 | 4.4 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.2 | 0.4 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.2 | 0.5 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.2 | 1.1 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.2 | 0.2 | GO:0035627 | ceramide transport(GO:0035627) |
0.2 | 0.2 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.2 | 2.1 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.2 | 1.0 | GO:0007031 | peroxisome organization(GO:0007031) |
0.2 | 0.3 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.2 | 1.2 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.2 | 2.4 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.2 | 1.4 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.2 | 0.9 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.2 | 0.7 | GO:0061117 | negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of heart growth(GO:0061117) |
0.2 | 0.3 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.2 | 0.3 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.2 | 0.5 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.2 | 0.3 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.2 | 11.5 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.2 | 0.7 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.2 | 3.5 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.2 | 0.5 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.2 | 0.5 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.2 | 0.3 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.2 | 2.1 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.2 | 0.2 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.2 | 0.5 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.2 | 0.5 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.2 | 0.8 | GO:0046415 | urate metabolic process(GO:0046415) |
0.2 | 0.5 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.2 | 0.2 | GO:0035624 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.2 | 0.8 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.2 | 0.6 | GO:0002645 | positive regulation of tolerance induction(GO:0002645) |
0.2 | 0.6 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.2 | 1.0 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.2 | 0.6 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.2 | 1.0 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.2 | 0.8 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.2 | 0.3 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.2 | 0.3 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.2 | 1.7 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.2 | 0.3 | GO:0052472 | modulation by host of viral transcription(GO:0043921) modulation of transcription in other organism involved in symbiotic interaction(GO:0052312) modulation by host of symbiont transcription(GO:0052472) |
0.2 | 0.5 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.2 | 0.6 | GO:0000956 | nuclear-transcribed mRNA catabolic process(GO:0000956) |
0.2 | 0.3 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.2 | 0.6 | GO:0046130 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.2 | 2.8 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.2 | 0.6 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.2 | 0.3 | GO:0070555 | response to interleukin-1(GO:0070555) |
0.2 | 0.8 | GO:0051013 | microtubule severing(GO:0051013) |
0.2 | 0.8 | GO:0043153 | photoperiodism(GO:0009648) entrainment of circadian clock by photoperiod(GO:0043153) |
0.2 | 0.9 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.2 | 0.3 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.2 | 1.5 | GO:0033081 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.2 | 1.1 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) |
0.2 | 0.2 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.2 | 0.9 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.2 | 0.5 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.2 | 0.8 | GO:0042168 | heme metabolic process(GO:0042168) |
0.2 | 0.2 | GO:0014735 | regulation of muscle atrophy(GO:0014735) |
0.2 | 0.3 | GO:0071941 | nitrogen cycle metabolic process(GO:0071941) |
0.2 | 0.2 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.2 | 2.6 | GO:0006284 | base-excision repair(GO:0006284) |
0.2 | 0.3 | GO:0060405 | regulation of penile erection(GO:0060405) positive regulation of penile erection(GO:0060406) |
0.2 | 1.1 | GO:0072337 | modified amino acid transport(GO:0072337) |
0.2 | 0.2 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.2 | 0.8 | GO:0048821 | erythrocyte development(GO:0048821) |
0.2 | 0.9 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.2 | 0.5 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.1 | 0.1 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.1 | 0.6 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.1 | 1.2 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.1 | 2.8 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.1 | 0.9 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.1 | 0.7 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.1 | 1.2 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 0.9 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.1 | 0.4 | GO:0031577 | spindle checkpoint(GO:0031577) |
0.1 | 0.1 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.1 | 0.7 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 0.1 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.1 | 0.1 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.1 | 1.3 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.1 | 0.3 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.1 | 3.0 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.1 | 0.1 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 0.7 | GO:0009251 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.1 | 3.1 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.6 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 2.4 | GO:0030239 | myofibril assembly(GO:0030239) |
0.1 | 3.7 | GO:0007569 | cell aging(GO:0007569) |
0.1 | 1.6 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 0.3 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.1 | 0.4 | GO:1990748 | cellular detoxification(GO:1990748) |
0.1 | 0.3 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 0.3 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.1 | 0.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.3 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.1 | 0.3 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.1 | 0.4 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.1 | 0.3 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.1 | 0.1 | GO:1902188 | positive regulation of viral release from host cell(GO:1902188) |
0.1 | 0.7 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.1 | 0.4 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.1 | 0.4 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.1 | 0.3 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.1 | 0.3 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.1 | 0.1 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.1 | 0.9 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.1 | 0.4 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.1 | 0.5 | GO:0032392 | DNA geometric change(GO:0032392) |
0.1 | 1.3 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
0.1 | 0.3 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
0.1 | 1.7 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
0.1 | 0.1 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.1 | 2.7 | GO:0051225 | spindle assembly(GO:0051225) |
0.1 | 1.1 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.1 | 0.1 | GO:0071608 | macrophage inflammatory protein-1 alpha production(GO:0071608) negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.1 | 0.1 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.1 | 0.3 | GO:0045780 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.1 | 1.3 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.1 | 0.3 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.1 | 0.8 | GO:0060897 | neural plate anterior/posterior regionalization(GO:0021999) neural plate regionalization(GO:0060897) |
0.1 | 0.3 | GO:0032462 | regulation of protein homooligomerization(GO:0032462) positive regulation of protein homooligomerization(GO:0032464) |
0.1 | 8.5 | GO:0006457 | protein folding(GO:0006457) |
0.1 | 0.3 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.1 | 0.5 | GO:0009299 | mRNA transcription(GO:0009299) |
0.1 | 0.5 | GO:0008209 | androgen metabolic process(GO:0008209) |
0.1 | 0.3 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.1 | 0.7 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.1 | 1.3 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
0.1 | 0.5 | GO:0071569 | protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.1 | 0.8 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 2.0 | GO:0006096 | glycolytic process(GO:0006096) |
0.1 | 0.7 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.1 | GO:0051177 | meiosis II(GO:0007135) meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.1 | 0.3 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.1 | 0.4 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
0.1 | 0.1 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.1 | 0.5 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.1 | 2.2 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.1 | 0.3 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.1 | 0.3 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.1 | 0.6 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 0.5 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.1 | 2.3 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 0.5 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.1 | 0.4 | GO:0001826 | inner cell mass cell differentiation(GO:0001826) |
0.1 | 0.4 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.1 | 0.1 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) |
0.1 | 2.2 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.1 | 1.0 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.1 | 2.2 | GO:0051289 | protein homotetramerization(GO:0051289) |
0.1 | 0.2 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.1 | 1.0 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.4 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 0.1 | GO:0002638 | negative regulation of immunoglobulin production(GO:0002638) |
0.1 | 0.2 | GO:0060768 | regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
0.1 | 0.5 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.1 | 0.2 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.1 | 0.1 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.1 | 0.1 | GO:1904751 | protein localization to nucleolus(GO:1902570) regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.1 | 0.2 | GO:0048242 | epinephrine secretion(GO:0048242) |
0.1 | 3.1 | GO:0030168 | platelet activation(GO:0030168) |
0.1 | 0.1 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) |
0.1 | 0.6 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.1 | 0.4 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.1 | 0.8 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.1 | 0.2 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 4.2 | GO:0030593 | neutrophil chemotaxis(GO:0030593) |
0.1 | 0.6 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.1 | 0.6 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.1 | 1.5 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.1 | 6.1 | GO:0008033 | tRNA processing(GO:0008033) |
0.1 | 1.4 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.1 | 0.7 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
0.1 | 0.6 | GO:0060717 | chorion development(GO:0060717) extraembryonic membrane development(GO:1903867) |
0.1 | 0.1 | GO:0001767 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
0.1 | 0.6 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 2.4 | GO:1903509 | liposaccharide metabolic process(GO:1903509) |
0.1 | 0.5 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.1 | 0.5 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.5 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 1.5 | GO:0060143 | positive regulation of syncytium formation by plasma membrane fusion(GO:0060143) |
0.1 | 0.3 | GO:0001659 | temperature homeostasis(GO:0001659) |
0.1 | 0.2 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.2 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.1 | 0.6 | GO:0061515 | myeloid cell development(GO:0061515) |
0.1 | 0.1 | GO:0051181 | cofactor transport(GO:0051181) |
0.1 | 0.1 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.1 | 1.8 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.1 | 0.1 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.1 | 0.3 | GO:1902047 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 0.7 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.1 | 0.3 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.1 | 1.3 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 0.5 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.1 | 0.5 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.1 | 0.1 | GO:0030421 | defecation(GO:0030421) |
0.1 | 0.2 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.1 | 0.4 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.1 | 0.3 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.1 | 0.5 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.1 | 2.5 | GO:0005977 | glycogen metabolic process(GO:0005977) cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
0.1 | 0.3 | GO:0001842 | neural fold formation(GO:0001842) |
0.1 | 0.5 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.1 | 0.7 | GO:0016045 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.1 | 2.0 | GO:0015807 | L-amino acid transport(GO:0015807) |
0.1 | 0.4 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.1 | 0.9 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.1 | 0.1 | GO:0046070 | dGTP metabolic process(GO:0046070) |
0.1 | 0.1 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.1 | 0.1 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
0.1 | 0.1 | GO:0002830 | positive regulation of type 2 immune response(GO:0002830) |
0.1 | 0.1 | GO:0032905 | transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) |
0.1 | 0.1 | GO:1904261 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.1 | 0.2 | GO:0002215 | defense response to nematode(GO:0002215) |
0.1 | 0.3 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.1 | 0.1 | GO:1900222 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) negative regulation of beta-amyloid clearance(GO:1900222) |
0.1 | 0.1 | GO:0038093 | Fc receptor signaling pathway(GO:0038093) |
0.1 | 0.1 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.1 | 0.1 | GO:0046112 | nucleobase biosynthetic process(GO:0046112) |
0.1 | 0.4 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.1 | 0.5 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 0.6 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.1 | 0.2 | GO:0015755 | fructose transport(GO:0015755) |
0.1 | 0.4 | GO:0043687 | post-translational protein modification(GO:0043687) |
0.1 | 5.0 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.1 | 2.1 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.1 | 0.2 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.1 | 0.7 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.1 | 0.8 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 2.3 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
0.1 | 0.1 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.1 | 0.2 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.1 | 0.2 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.1 | 0.6 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 0.1 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.1 | 0.1 | GO:0070989 | oxidative demethylation(GO:0070989) |
0.1 | 0.4 | GO:0044116 | growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) |
0.1 | 11.1 | GO:0008380 | RNA splicing(GO:0008380) |
0.1 | 0.4 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.1 | 2.0 | GO:0002455 | humoral immune response mediated by circulating immunoglobulin(GO:0002455) |
0.1 | 2.5 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.1 | 0.6 | GO:0070266 | necroptotic process(GO:0070266) |
0.1 | 0.7 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 0.4 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 0.6 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.1 | 0.3 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.1 | 0.7 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
0.1 | 0.7 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 0.6 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 0.4 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.1 | 0.3 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
0.1 | 0.5 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.1 | 0.2 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.1 | 1.3 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.1 | 0.2 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) |
0.1 | 0.2 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.1 | 0.1 | GO:0006984 | ER-nucleus signaling pathway(GO:0006984) |
0.1 | 2.1 | GO:0098840 | protein transport along microtubule(GO:0098840) |
0.1 | 1.0 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.4 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 0.1 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.1 | 1.4 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
0.1 | 0.3 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.1 | 0.4 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.1 | 2.0 | GO:0006413 | translational initiation(GO:0006413) |
0.1 | 0.1 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.1 | 0.2 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.1 | 0.3 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 0.2 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 2.4 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.1 | 0.1 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.1 | 0.1 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.1 | 0.1 | GO:0071223 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.1 | 0.7 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.1 | 5.9 | GO:0022613 | ribonucleoprotein complex biogenesis(GO:0022613) |
0.1 | 0.1 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.1 | 0.8 | GO:0006165 | nucleoside diphosphate phosphorylation(GO:0006165) |
0.1 | 0.1 | GO:0014900 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.1 | 0.2 | GO:0002584 | negative regulation of antigen processing and presentation(GO:0002578) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.1 | 0.2 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.1 | 0.2 | GO:0032753 | positive regulation of interleukin-4 production(GO:0032753) |
0.1 | 2.8 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.1 | 0.1 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.1 | 0.5 | GO:0010388 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.1 | 0.2 | GO:1990266 | neutrophil migration(GO:1990266) |
0.1 | 0.3 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.1 | 0.1 | GO:0090042 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.1 | 0.2 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.1 | 0.1 | GO:0035973 | aggrephagy(GO:0035973) |
0.1 | 0.2 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.1 | 0.7 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.1 | GO:0044362 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.1 | 0.9 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.1 | 1.2 | GO:0055092 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.1 | 0.1 | GO:0032570 | response to progesterone(GO:0032570) |
0.1 | 0.1 | GO:0032371 | regulation of sterol transport(GO:0032371) regulation of cholesterol transport(GO:0032374) |
0.1 | 0.9 | GO:0006818 | hydrogen transport(GO:0006818) |
0.1 | 0.4 | GO:0045056 | transcytosis(GO:0045056) |
0.1 | 0.1 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 0.2 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.2 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.1 | 0.1 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.1 | 0.1 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.1 | 0.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 0.4 | GO:0097286 | iron ion import(GO:0097286) |
0.1 | 1.1 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.1 | 0.1 | GO:0010225 | response to UV-C(GO:0010225) |
0.1 | 0.1 | GO:1901533 | negative regulation of hematopoietic progenitor cell differentiation(GO:1901533) |
0.1 | 0.1 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.1 | 0.1 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.1 | 0.1 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.1 | 0.6 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.1 | 0.3 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.1 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.1 | 0.4 | GO:1900744 | regulation of p38MAPK cascade(GO:1900744) |
0.1 | 0.2 | GO:0006497 | protein lipidation(GO:0006497) |
0.1 | 2.1 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.1 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.1 | 0.2 | GO:0061013 | regulation of mRNA catabolic process(GO:0061013) |
0.1 | 0.9 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.2 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 0.1 | GO:0086029 | Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
0.1 | 0.3 | GO:0007143 | female meiotic division(GO:0007143) |
0.1 | 0.5 | GO:1902686 | positive regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902110) mitochondrial outer membrane permeabilization involved in programmed cell death(GO:1902686) |
0.1 | 0.5 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.1 | 0.1 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.1 | 0.1 | GO:0046135 | pyrimidine nucleoside catabolic process(GO:0046135) |
0.1 | 0.1 | GO:0003096 | renal sodium ion transport(GO:0003096) |
0.1 | 0.1 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.1 | 0.3 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.1 | 0.1 | GO:0006399 | tRNA metabolic process(GO:0006399) |
0.1 | 2.8 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.1 | 0.1 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.1 | 0.3 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.1 | 0.1 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.1 | 0.1 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.1 | 0.2 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.1 | 0.1 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
0.1 | 0.2 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.1 | 0.1 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.1 | 0.4 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.1 | 0.1 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.1 | 0.4 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 0.1 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 0.1 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.1 | 0.1 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.1 | 0.1 | GO:2000510 | regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.1 | 1.0 | GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
0.1 | 0.1 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.1 | 0.1 | GO:0032439 | endosome localization(GO:0032439) |
0.1 | 0.1 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 0.1 | GO:0019471 | 4-hydroxyproline metabolic process(GO:0019471) |
0.1 | 0.3 | GO:1902473 | regulation of protein localization to synapse(GO:1902473) |
0.1 | 0.1 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.1 | 0.3 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.1 | 0.6 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.1 | 1.8 | GO:0010822 | positive regulation of mitochondrion organization(GO:0010822) |
0.1 | 0.1 | GO:0001765 | membrane raft assembly(GO:0001765) |
0.1 | 0.1 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.1 | 0.3 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 0.1 | GO:0002200 | somatic diversification of immune receptors(GO:0002200) |
0.1 | 0.1 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.1 | 0.1 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.1 | 0.2 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.1 | 0.1 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.1 | 0.1 | GO:0006925 | inflammatory cell apoptotic process(GO:0006925) |
0.1 | 0.2 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.2 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.1 | 0.2 | GO:0008214 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.1 | 0.4 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.1 | 0.1 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.1 | 0.2 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.1 | 1.8 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.1 | 0.1 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.1 | 0.3 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 0.3 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.1 | 0.3 | GO:0046836 | glycolipid transport(GO:0046836) |
0.1 | 0.2 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.1 | 0.3 | GO:0032965 | regulation of collagen biosynthetic process(GO:0032965) |
0.0 | 0.0 | GO:0045346 | MHC class II biosynthetic process(GO:0045342) regulation of MHC class II biosynthetic process(GO:0045346) |
0.0 | 0.0 | GO:1903019 | negative regulation of glycoprotein metabolic process(GO:1903019) |
0.0 | 0.2 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.0 | 0.0 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.0 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.0 | 0.5 | GO:1900046 | regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
0.0 | 0.0 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.0 | 1.4 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.0 | 0.0 | GO:0097531 | mast cell migration(GO:0097531) |
0.0 | 0.0 | GO:0046640 | regulation of alpha-beta T cell proliferation(GO:0046640) |
0.0 | 0.3 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.5 | GO:1902572 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 1.5 | GO:0007059 | chromosome segregation(GO:0007059) |
0.0 | 1.1 | GO:0006310 | DNA recombination(GO:0006310) |
0.0 | 0.8 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.0 | 0.1 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.0 | 0.1 | GO:0030575 | nuclear body organization(GO:0030575) |
0.0 | 0.1 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.0 | 0.2 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.0 | 0.3 | GO:0002347 | response to tumor cell(GO:0002347) |
0.0 | 0.0 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.0 | 0.0 | GO:1902591 | single-organism membrane budding(GO:1902591) |
0.0 | 0.0 | GO:0097300 | programmed necrotic cell death(GO:0097300) |
0.0 | 0.0 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.0 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.0 | 0.4 | GO:0007602 | phototransduction(GO:0007602) |
0.0 | 0.2 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.0 | 0.1 | GO:0042558 | pteridine-containing compound metabolic process(GO:0042558) |
0.0 | 0.1 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) |
0.0 | 0.1 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.0 | 0.0 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.0 | 0.0 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.0 | 0.0 | GO:0001774 | microglial cell activation(GO:0001774) |
0.0 | 0.1 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.0 | 0.0 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.0 | 0.0 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.0 | 2.8 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.0 | 0.0 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) |
0.0 | 0.0 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.0 | 0.1 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.0 | 0.1 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.0 | 0.2 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.0 | 0.1 | GO:0009624 | response to nematode(GO:0009624) |
0.0 | 0.1 | GO:0002775 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
0.0 | 0.0 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.0 | 0.1 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.0 | 0.1 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.0 | 0.1 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.0 | 0.0 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.0 | 0.0 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.0 | 0.0 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.0 | 0.1 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.0 | 0.0 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.0 | 0.2 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.0 | 0.1 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.0 | 0.0 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.0 | 0.5 | GO:0006953 | acute-phase response(GO:0006953) |
0.0 | 0.2 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.0 | 0.0 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.0 | 0.2 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.0 | 0.3 | GO:0042157 | lipoprotein metabolic process(GO:0042157) |
0.0 | 0.2 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.0 | 0.2 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.0 | 0.6 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 0.1 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.0 | 0.1 | GO:0002251 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.0 | 0.0 | GO:0061384 | heart trabecula formation(GO:0060347) heart trabecula morphogenesis(GO:0061384) |
0.0 | 0.5 | GO:0009813 | flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.0 | 0.0 | GO:1902931 | negative regulation of alcohol biosynthetic process(GO:1902931) |
0.0 | 0.1 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
0.0 | 0.2 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.0 | 0.1 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.0 | 0.0 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.0 | 2.7 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.0 | GO:0016073 | snRNA metabolic process(GO:0016073) |
0.0 | 0.1 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.0 | 0.1 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.0 | 0.0 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) |
0.0 | 0.0 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.0 | 0.0 | GO:0006298 | mismatch repair(GO:0006298) |
0.0 | 0.2 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.0 | 0.1 | GO:0090559 | regulation of membrane permeability(GO:0090559) |
0.0 | 0.1 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
0.0 | 0.0 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.0 | 0.0 | GO:0043467 | regulation of generation of precursor metabolites and energy(GO:0043467) |
0.0 | 0.0 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.0 | 0.0 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.0 | 0.0 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.0 | 0.0 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.0 | 0.0 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.0 | 0.1 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.0 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.1 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.0 | 0.0 | GO:0034770 | histone H4-K20 methylation(GO:0034770) histone H4-K20 trimethylation(GO:0034773) |
0.0 | 0.1 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.0 | 0.1 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.0 | 0.0 | GO:0051665 | membrane raft localization(GO:0051665) |
0.0 | 0.0 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.0 | 0.1 | GO:0002507 | tolerance induction(GO:0002507) |
0.0 | 0.2 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.0 | 0.0 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.0 | GO:0051299 | centrosome separation(GO:0051299) |
0.0 | 0.1 | GO:0018101 | protein citrullination(GO:0018101) |
0.0 | 0.1 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.0 | 0.0 | GO:0019755 | urea transport(GO:0015840) one-carbon compound transport(GO:0019755) |
0.0 | 0.1 | GO:1903363 | negative regulation of cellular protein catabolic process(GO:1903363) |
0.0 | 0.0 | GO:0002637 | regulation of immunoglobulin production(GO:0002637) |
0.0 | 0.0 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.0 | 0.0 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.0 | 0.0 | GO:0046621 | negative regulation of organ growth(GO:0046621) |
0.0 | 0.0 | GO:0070417 | cellular response to cold(GO:0070417) |
0.0 | 0.0 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.0 | 0.1 | GO:0046173 | polyol biosynthetic process(GO:0046173) |
0.0 | 0.1 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.0 | 0.0 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.0 | 0.0 | GO:1900193 | regulation of oocyte maturation(GO:1900193) |
0.0 | 0.0 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.0 | 0.0 | GO:0044381 | glucose import in response to insulin stimulus(GO:0044381) regulation of glucose import in response to insulin stimulus(GO:2001273) |
0.0 | 0.0 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.0 | 0.0 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.0 | 0.0 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.0 | 0.0 | GO:0010984 | regulation of lipoprotein particle clearance(GO:0010984) |
0.0 | 0.1 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.0 | 0.0 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.0 | 0.0 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.0 | 0.2 | GO:0001783 | B cell apoptotic process(GO:0001783) |
0.0 | 0.0 | GO:0045297 | mating plug formation(GO:0042628) post-mating behavior(GO:0045297) |
0.0 | 0.0 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.0 | 0.0 | GO:0060295 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 16.6 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
1.7 | 6.9 | GO:0070876 | SOSS complex(GO:0070876) |
1.7 | 5.0 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
1.5 | 5.9 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
1.4 | 7.0 | GO:0031298 | replication fork protection complex(GO:0031298) |
1.4 | 6.9 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
1.3 | 2.7 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
1.2 | 3.5 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
1.1 | 3.4 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
1.1 | 4.5 | GO:0045293 | mRNA editing complex(GO:0045293) |
1.1 | 5.6 | GO:0005579 | membrane attack complex(GO:0005579) |
1.1 | 3.4 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
1.1 | 6.6 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
1.1 | 3.2 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
1.1 | 3.2 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
1.1 | 11.8 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
1.1 | 7.4 | GO:0005577 | fibrinogen complex(GO:0005577) |
1.0 | 4.2 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.9 | 3.8 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.9 | 8.5 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
0.9 | 14.0 | GO:0031430 | M band(GO:0031430) |
0.9 | 4.6 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.9 | 5.3 | GO:0097342 | ripoptosome(GO:0097342) |
0.9 | 2.6 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.8 | 6.8 | GO:0005861 | troponin complex(GO:0005861) |
0.8 | 5.0 | GO:0031983 | vesicle lumen(GO:0031983) |
0.8 | 2.4 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.8 | 1.6 | GO:0005915 | zonula adherens(GO:0005915) |
0.8 | 2.4 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.8 | 0.8 | GO:0033269 | internode region of axon(GO:0033269) |
0.8 | 2.3 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.7 | 3.7 | GO:0005638 | lamin filament(GO:0005638) |
0.7 | 5.9 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.7 | 8.1 | GO:0042555 | MCM complex(GO:0042555) |
0.7 | 2.2 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.7 | 0.7 | GO:0061574 | ASAP complex(GO:0061574) |
0.7 | 2.9 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.7 | 2.8 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.7 | 1.4 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.7 | 1.3 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.7 | 4.0 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.7 | 2.6 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.7 | 5.2 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.6 | 3.8 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.6 | 2.5 | GO:1990246 | uniplex complex(GO:1990246) |
0.6 | 1.9 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.6 | 1.9 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.6 | 2.5 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.6 | 1.8 | GO:1990462 | omegasome(GO:1990462) |
0.6 | 4.0 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.6 | 5.7 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.6 | 7.4 | GO:0042581 | specific granule(GO:0042581) |
0.6 | 1.7 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.6 | 18.6 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.6 | 3.9 | GO:0005652 | nuclear lamina(GO:0005652) |
0.6 | 3.9 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.5 | 3.3 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.5 | 3.8 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.5 | 3.3 | GO:0031415 | NatA complex(GO:0031415) |
0.5 | 4.9 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.5 | 2.2 | GO:0016600 | flotillin complex(GO:0016600) |
0.5 | 1.6 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.5 | 7.5 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.5 | 2.1 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.5 | 4.8 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.5 | 3.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.5 | 1.6 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.5 | 4.2 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.5 | 6.3 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.5 | 2.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.5 | 2.6 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.5 | 1.5 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.5 | 5.0 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.5 | 3.5 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.5 | 2.5 | GO:0097422 | tubular endosome(GO:0097422) |
0.5 | 1.5 | GO:0070552 | BRISC complex(GO:0070552) |
0.5 | 1.0 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.5 | 43.5 | GO:0072562 | blood microparticle(GO:0072562) |
0.5 | 1.4 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.5 | 6.7 | GO:0001891 | phagocytic cup(GO:0001891) |
0.5 | 0.5 | GO:0089701 | U2AF(GO:0089701) |
0.5 | 18.6 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.5 | 1.9 | GO:0035859 | Seh1-associated complex(GO:0035859) |
0.5 | 2.4 | GO:0016589 | NURF complex(GO:0016589) |
0.5 | 1.4 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.5 | 0.9 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.5 | 3.2 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.5 | 3.2 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.5 | 2.7 | GO:0001739 | sex chromatin(GO:0001739) |
0.5 | 3.2 | GO:0001650 | fibrillar center(GO:0001650) |
0.4 | 2.2 | GO:0030870 | Mre11 complex(GO:0030870) |
0.4 | 0.9 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.4 | 7.1 | GO:0031672 | A band(GO:0031672) |
0.4 | 3.5 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.4 | 4.8 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.4 | 1.8 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.4 | 2.2 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.4 | 2.6 | GO:0000796 | condensin complex(GO:0000796) |
0.4 | 5.2 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.4 | 1.3 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.4 | 6.0 | GO:0031528 | microvillus membrane(GO:0031528) |
0.4 | 3.8 | GO:0005682 | U5 snRNP(GO:0005682) |
0.4 | 2.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.4 | 19.1 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.4 | 1.7 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.4 | 1.2 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.4 | 1.2 | GO:0097413 | Lewy body(GO:0097413) |
0.4 | 3.2 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.4 | 2.4 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.4 | 4.8 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.4 | 1.6 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.4 | 2.0 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.4 | 1.2 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.4 | 8.7 | GO:0030894 | replisome(GO:0030894) |
0.4 | 2.4 | GO:0098651 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.4 | 0.8 | GO:0035861 | site of double-strand break(GO:0035861) |
0.4 | 1.6 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.4 | 2.3 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.4 | 1.5 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.4 | 0.4 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.4 | 1.5 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.4 | 3.8 | GO:0032039 | integrator complex(GO:0032039) |
0.4 | 1.5 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.4 | 1.5 | GO:0042825 | TAP complex(GO:0042825) |
0.4 | 1.5 | GO:0098536 | deuterosome(GO:0098536) |
0.4 | 1.9 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.4 | 2.2 | GO:0070847 | core mediator complex(GO:0070847) |
0.4 | 3.0 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.4 | 1.8 | GO:0000805 | X chromosome(GO:0000805) |
0.4 | 1.1 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.4 | 0.7 | GO:0071797 | LUBAC complex(GO:0071797) |
0.4 | 1.4 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.4 | 4.9 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.4 | 3.2 | GO:0016580 | Sin3 complex(GO:0016580) |
0.4 | 1.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.3 | 3.1 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.3 | 4.9 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.3 | 2.8 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.3 | 4.9 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.3 | 1.7 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.3 | 2.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.3 | 1.4 | GO:0005869 | dynactin complex(GO:0005869) |
0.3 | 3.1 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.3 | 0.7 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.3 | 2.4 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.3 | 1.0 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.3 | 5.6 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.3 | 8.9 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.3 | 2.3 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.3 | 1.0 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.3 | 3.2 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.3 | 1.6 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.3 | 1.6 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.3 | 1.0 | GO:0005914 | spot adherens junction(GO:0005914) |
0.3 | 0.6 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.3 | 1.9 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.3 | 2.2 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.3 | 6.8 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.3 | 3.4 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.3 | 2.5 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.3 | 16.0 | GO:0005811 | lipid particle(GO:0005811) |
0.3 | 1.2 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.3 | 1.5 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.3 | 0.9 | GO:0000125 | PCAF complex(GO:0000125) |
0.3 | 0.9 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.3 | 1.2 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.3 | 1.2 | GO:0042583 | chromaffin granule(GO:0042583) |
0.3 | 1.2 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.3 | 13.7 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.3 | 1.5 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.3 | 1.2 | GO:0045180 | basal cortex(GO:0045180) |
0.3 | 0.9 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.3 | 1.8 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.3 | 0.3 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.3 | 4.1 | GO:0030904 | retromer complex(GO:0030904) |
0.3 | 0.9 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.3 | 1.8 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.3 | 0.3 | GO:0005642 | annulate lamellae(GO:0005642) |
0.3 | 25.8 | GO:0000793 | condensed chromosome(GO:0000793) |
0.3 | 1.7 | GO:0070469 | respiratory chain(GO:0070469) |
0.3 | 12.4 | GO:0005643 | nuclear pore(GO:0005643) |
0.3 | 1.7 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.3 | 2.0 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.3 | 3.1 | GO:0005685 | U1 snRNP(GO:0005685) |
0.3 | 0.6 | GO:0016939 | kinesin II complex(GO:0016939) |
0.3 | 0.9 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.3 | 20.4 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.3 | 0.6 | GO:0018995 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.3 | 1.7 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.3 | 0.8 | GO:0072487 | MSL complex(GO:0072487) |
0.3 | 6.7 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.3 | 15.9 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.3 | 0.8 | GO:1990923 | PET complex(GO:1990923) |
0.3 | 1.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.3 | 0.8 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.3 | 2.5 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.3 | 1.1 | GO:0030891 | VCB complex(GO:0030891) |
0.3 | 1.9 | GO:0031931 | TORC1 complex(GO:0031931) |
0.3 | 10.2 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.3 | 1.3 | GO:0031143 | pseudopodium(GO:0031143) |
0.3 | 2.4 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.3 | 0.3 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.3 | 1.3 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.3 | 2.3 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.3 | 2.3 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.3 | 15.1 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.3 | 2.8 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.2 | 1.2 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.2 | 1.7 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.2 | 1.0 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.2 | 0.7 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.2 | 0.2 | GO:0016460 | myosin II complex(GO:0016460) |
0.2 | 2.0 | GO:0070652 | HAUS complex(GO:0070652) |
0.2 | 2.9 | GO:0005916 | fascia adherens(GO:0005916) |
0.2 | 9.4 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.2 | 1.9 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.2 | 1.9 | GO:0002102 | podosome(GO:0002102) |
0.2 | 0.2 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.2 | 1.0 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.2 | 4.5 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.2 | 1.0 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.2 | 1.2 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.2 | 0.7 | GO:0048179 | activin receptor complex(GO:0048179) |
0.2 | 0.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.2 | 2.1 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.2 | 0.9 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.2 | 61.0 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.2 | 0.7 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.2 | 1.8 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.2 | 2.0 | GO:0000346 | transcription export complex(GO:0000346) |
0.2 | 0.2 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.2 | 1.3 | GO:0042629 | mast cell granule(GO:0042629) |
0.2 | 4.4 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.2 | 2.2 | GO:0045120 | pronucleus(GO:0045120) |
0.2 | 0.4 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.2 | 4.8 | GO:0001772 | immunological synapse(GO:0001772) |
0.2 | 1.7 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.2 | 1.7 | GO:0000124 | SAGA complex(GO:0000124) |
0.2 | 1.3 | GO:0071986 | Ragulator complex(GO:0071986) |
0.2 | 2.8 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.2 | 20.4 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.2 | 0.4 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.2 | 1.1 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.2 | 1.7 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.2 | 0.8 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.2 | 1.2 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.2 | 5.3 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.2 | 0.4 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.2 | 24.2 | GO:0005819 | spindle(GO:0005819) |
0.2 | 1.4 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.2 | 1.2 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.2 | 2.6 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.2 | 0.6 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.2 | 2.7 | GO:0031011 | Ino80 complex(GO:0031011) |
0.2 | 10.9 | GO:0005795 | Golgi stack(GO:0005795) |
0.2 | 0.6 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.2 | 0.6 | GO:0000322 | storage vacuole(GO:0000322) |
0.2 | 0.4 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.2 | 0.4 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.2 | 1.3 | GO:1902562 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.2 | 5.5 | GO:0016592 | mediator complex(GO:0016592) |
0.2 | 1.5 | GO:0000242 | pericentriolar material(GO:0000242) |
0.2 | 0.6 | GO:0097443 | sorting endosome(GO:0097443) |
0.2 | 0.7 | GO:0031932 | TORC2 complex(GO:0031932) |
0.2 | 1.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.2 | 0.6 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.2 | 20.4 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.2 | 0.2 | GO:1990752 | microtubule end(GO:1990752) |
0.2 | 1.1 | GO:0042382 | paraspeckles(GO:0042382) |
0.2 | 1.3 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.2 | 14.2 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.2 | 0.2 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.2 | 0.9 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.2 | 0.4 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
0.2 | 0.2 | GO:0032432 | actin filament bundle(GO:0032432) |
0.2 | 0.4 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.2 | 7.6 | GO:0042641 | actomyosin(GO:0042641) |
0.2 | 2.1 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.2 | 0.2 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 0.9 | GO:0034709 | methylosome(GO:0034709) |
0.2 | 0.2 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.2 | 1.4 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.2 | 0.5 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.2 | 0.2 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.2 | 3.4 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.2 | 2.9 | GO:0032040 | small-subunit processome(GO:0032040) |
0.2 | 2.2 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.2 | 0.7 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.2 | 15.2 | GO:0005770 | late endosome(GO:0005770) |
0.2 | 4.6 | GO:0045171 | intercellular bridge(GO:0045171) |
0.2 | 1.0 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.2 | 2.6 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.2 | 0.2 | GO:0015934 | large ribosomal subunit(GO:0015934) |
0.2 | 1.5 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.2 | 0.5 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.2 | 5.5 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.2 | 3.0 | GO:0097610 | cell division site(GO:0032153) cleavage furrow(GO:0032154) cell division site part(GO:0032155) cell surface furrow(GO:0097610) |
0.2 | 138.0 | GO:0005739 | mitochondrion(GO:0005739) |
0.2 | 7.0 | GO:0010008 | endosome membrane(GO:0010008) |
0.2 | 9.3 | GO:0036064 | ciliary basal body(GO:0036064) |
0.2 | 2.2 | GO:0030057 | desmosome(GO:0030057) |
0.2 | 0.3 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.2 | 0.2 | GO:0090543 | Flemming body(GO:0090543) |
0.2 | 0.2 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.2 | 1.6 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.2 | 4.1 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.2 | 0.2 | GO:0035838 | growing cell tip(GO:0035838) |
0.2 | 0.5 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.2 | 0.5 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 1.9 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 0.1 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.4 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.7 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 1.5 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 3.7 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 2.5 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 0.1 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.1 | 2.6 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 4.5 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 0.4 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.1 | 1.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 0.1 | GO:1990357 | terminal web(GO:1990357) |
0.1 | 0.4 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 0.1 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.1 | 0.3 | GO:0097470 | ribbon synapse(GO:0097470) |
0.1 | 4.4 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 0.3 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 1.7 | GO:0005840 | ribosome(GO:0005840) |
0.1 | 6.2 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 1.4 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 0.7 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.1 | GO:0033010 | paranodal junction(GO:0033010) |
0.1 | 1.9 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.1 | 0.8 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.1 | 0.3 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.1 | 0.3 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 0.4 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 0.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.1 | 5.5 | GO:0016607 | nuclear speck(GO:0016607) |
0.1 | 20.8 | GO:0005925 | focal adhesion(GO:0005925) |
0.1 | 1.9 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.1 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.1 | 0.4 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 0.5 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.1 | 0.5 | GO:0035339 | SPOTS complex(GO:0035339) |
0.1 | 0.1 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.1 | 0.5 | GO:0070461 | SAGA-type complex(GO:0070461) |
0.1 | 0.8 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 3.0 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 1.6 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.4 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.1 | 0.9 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.1 | 85.8 | GO:0005829 | cytosol(GO:0005829) |
0.1 | 2.9 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 0.2 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 13.9 | GO:0031967 | organelle envelope(GO:0031967) envelope(GO:0031975) |
0.1 | 1.0 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 1.6 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.1 | 0.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 0.2 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 0.2 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 1.5 | GO:1990391 | DNA repair complex(GO:1990391) |
0.1 | 0.9 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 0.3 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.1 | 0.1 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.1 | 1.0 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 1.3 | GO:0000786 | nucleosome(GO:0000786) |
0.1 | 0.3 | GO:0070187 | telosome(GO:0070187) |
0.1 | 0.4 | GO:0097546 | ciliary base(GO:0097546) |
0.1 | 2.5 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 0.1 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.9 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.3 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.1 | 0.3 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.1 | 0.1 | GO:0033202 | DNA helicase complex(GO:0033202) |
0.1 | 0.5 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 0.7 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.1 | 0.9 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 2.1 | GO:0016605 | PML body(GO:0016605) |
0.1 | 3.6 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 13.4 | GO:0005813 | centrosome(GO:0005813) |
0.1 | 2.0 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.1 | 0.7 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
0.1 | 0.1 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.1 | 0.6 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.1 | 0.6 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 0.3 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.1 | 3.7 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 0.2 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 0.2 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 0.6 | GO:0030686 | 90S preribosome(GO:0030686) |
0.1 | 0.6 | GO:0090544 | BAF-type complex(GO:0090544) |
0.1 | 0.1 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.1 | 0.3 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 84.3 | GO:0070062 | extracellular exosome(GO:0070062) |
0.1 | 0.6 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.2 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 0.2 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
0.1 | 0.6 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 7.7 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 0.2 | GO:0005657 | replication fork(GO:0005657) |
0.1 | 0.8 | GO:0035770 | ribonucleoprotein granule(GO:0035770) |
0.1 | 0.2 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 0.2 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.0 | 3.0 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.0 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.0 | 0.6 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.2 | GO:0000938 | GARP complex(GO:0000938) |
0.0 | 0.1 | GO:0045179 | apical cortex(GO:0045179) |
0.0 | 31.6 | GO:0005654 | nucleoplasm(GO:0005654) |
0.0 | 4.6 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 0.0 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.0 | 0.0 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.0 | 1.0 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.0 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.0 | 0.2 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.0 | GO:0071439 | clathrin complex(GO:0071439) |
0.0 | 0.2 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.1 | GO:0045178 | basal part of cell(GO:0045178) |
0.0 | 0.1 | GO:0044452 | nucleolar part(GO:0044452) |
0.0 | 1.2 | GO:0005938 | cell cortex(GO:0005938) |
0.0 | 0.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 0.3 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.0 | 0.0 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.0 | 13.6 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 0.4 | GO:0005901 | caveola(GO:0005901) |
0.0 | 0.0 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.6 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.0 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.0 | 0.2 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.0 | 0.0 | GO:0061689 | tricellular tight junction(GO:0061689) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.7 | 14.0 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
3.5 | 10.5 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
2.9 | 8.6 | GO:0070538 | oleic acid binding(GO:0070538) |
2.7 | 8.2 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
1.8 | 7.2 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
1.7 | 11.8 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
1.5 | 7.7 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
1.4 | 4.3 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
1.4 | 4.3 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
1.4 | 5.6 | GO:0043515 | kinetochore binding(GO:0043515) |
1.4 | 8.4 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
1.3 | 4.0 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
1.3 | 9.1 | GO:0003688 | DNA replication origin binding(GO:0003688) |
1.3 | 5.1 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
1.2 | 3.7 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
1.2 | 1.2 | GO:0017166 | vinculin binding(GO:0017166) |
1.2 | 4.9 | GO:0031433 | telethonin binding(GO:0031433) |
1.2 | 4.7 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
1.2 | 8.3 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
1.2 | 3.5 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
1.2 | 3.5 | GO:0030172 | troponin C binding(GO:0030172) |
1.2 | 3.5 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
1.1 | 4.6 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
1.1 | 3.4 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
1.1 | 5.6 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
1.1 | 8.7 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
1.1 | 3.2 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
1.1 | 4.2 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
1.0 | 3.1 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
1.0 | 3.1 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
1.0 | 3.0 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
1.0 | 3.0 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
1.0 | 1.0 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
1.0 | 3.0 | GO:0019961 | interferon binding(GO:0019961) |
1.0 | 2.9 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
1.0 | 3.8 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.9 | 2.8 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.9 | 3.7 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.9 | 3.7 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.9 | 6.5 | GO:0003896 | DNA primase activity(GO:0003896) |
0.9 | 2.7 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.9 | 13.4 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.9 | 0.9 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.9 | 7.9 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.9 | 3.5 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.9 | 6.9 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.9 | 2.6 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.9 | 6.1 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.9 | 2.6 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.8 | 1.7 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.8 | 2.5 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.8 | 3.4 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.8 | 3.3 | GO:0030984 | kininogen binding(GO:0030984) |
0.8 | 5.8 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
0.8 | 2.5 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.8 | 2.5 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.8 | 4.8 | GO:0004064 | arylesterase activity(GO:0004064) |
0.8 | 1.6 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.8 | 7.9 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.8 | 4.8 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.8 | 3.2 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.8 | 5.5 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.8 | 6.3 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.8 | 2.3 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.8 | 4.6 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.8 | 4.5 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.7 | 2.2 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.7 | 11.0 | GO:0035173 | histone kinase activity(GO:0035173) |
0.7 | 3.7 | GO:0016151 | nickel cation binding(GO:0016151) |
0.7 | 2.9 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.7 | 3.6 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.7 | 3.4 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.7 | 2.0 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.7 | 0.7 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.7 | 2.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.6 | 3.2 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.6 | 1.9 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.6 | 1.3 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
0.6 | 1.9 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.6 | 5.7 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.6 | 2.5 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.6 | 3.0 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.6 | 1.8 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.6 | 0.6 | GO:0019808 | polyamine binding(GO:0019808) |
0.6 | 1.8 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.6 | 2.3 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.6 | 2.3 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.6 | 11.6 | GO:0030506 | ankyrin binding(GO:0030506) |
0.6 | 1.2 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.6 | 1.1 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.6 | 1.1 | GO:0034618 | arginine binding(GO:0034618) |
0.6 | 0.6 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.6 | 2.8 | GO:0070728 | leucine binding(GO:0070728) |
0.6 | 2.3 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.6 | 2.8 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.6 | 1.7 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.6 | 2.8 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.6 | 2.2 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.6 | 1.1 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.6 | 1.7 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.5 | 4.9 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.5 | 1.6 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.5 | 12.5 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.5 | 1.6 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.5 | 5.4 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.5 | 5.9 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.5 | 1.6 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.5 | 3.2 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.5 | 2.7 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.5 | 0.5 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.5 | 2.6 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.5 | 5.2 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.5 | 1.0 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.5 | 1.6 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.5 | 1.5 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.5 | 1.0 | GO:0019862 | IgA binding(GO:0019862) |
0.5 | 1.0 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.5 | 2.0 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.5 | 2.0 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.5 | 1.5 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.5 | 2.0 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.5 | 5.0 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.5 | 3.0 | GO:0052850 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.5 | 2.0 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.5 | 0.5 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.5 | 1.5 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.5 | 1.5 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.5 | 2.4 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.5 | 1.4 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.5 | 9.1 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.5 | 1.9 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.5 | 1.9 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.5 | 3.3 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.5 | 3.8 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.5 | 0.9 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.5 | 1.4 | GO:0048030 | disaccharide binding(GO:0048030) |
0.5 | 3.3 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.5 | 1.4 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.5 | 6.5 | GO:0019825 | oxygen binding(GO:0019825) |
0.5 | 1.4 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.5 | 2.8 | GO:0000182 | rDNA binding(GO:0000182) |
0.5 | 3.2 | GO:0034046 | poly(G) binding(GO:0034046) |
0.5 | 1.4 | GO:2001070 | starch binding(GO:2001070) |
0.5 | 1.4 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.5 | 1.4 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.5 | 0.5 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.5 | 2.3 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.4 | 1.8 | GO:0036033 | mediator complex binding(GO:0036033) |
0.4 | 0.9 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.4 | 5.8 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.4 | 0.4 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.4 | 1.8 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.4 | 0.4 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.4 | 0.9 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.4 | 1.3 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.4 | 1.7 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.4 | 5.2 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.4 | 14.8 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.4 | 1.3 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.4 | 11.2 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.4 | 3.0 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.4 | 1.7 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.4 | 1.7 | GO:0009374 | biotin binding(GO:0009374) |
0.4 | 0.9 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.4 | 2.1 | GO:0017040 | ceramidase activity(GO:0017040) |
0.4 | 1.7 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.4 | 2.1 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.4 | 1.3 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.4 | 1.3 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.4 | 4.7 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.4 | 2.1 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.4 | 6.3 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.4 | 3.8 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.4 | 1.3 | GO:0034862 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.4 | 2.1 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.4 | 7.0 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.4 | 1.6 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.4 | 1.2 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.4 | 0.4 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.4 | 1.6 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.4 | 1.2 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.4 | 1.2 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.4 | 2.8 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) |
0.4 | 7.2 | GO:0001848 | complement binding(GO:0001848) |
0.4 | 3.2 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.4 | 0.8 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.4 | 1.2 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.4 | 1.2 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.4 | 1.2 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.4 | 1.2 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.4 | 2.0 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.4 | 1.2 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.4 | 1.2 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.4 | 2.7 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.4 | 3.5 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.4 | 1.1 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.4 | 3.8 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.4 | 1.5 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.4 | 1.9 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.4 | 4.2 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.4 | 1.1 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.4 | 4.5 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.4 | 1.1 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.4 | 6.4 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.4 | 2.6 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.4 | 3.4 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.4 | 2.6 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.4 | 5.3 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
0.4 | 0.4 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.4 | 1.1 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.4 | 6.0 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.4 | 1.5 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.4 | 10.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.4 | 1.1 | GO:0051425 | PTB domain binding(GO:0051425) |
0.4 | 1.9 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.4 | 1.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.4 | 8.1 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.4 | 1.5 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.4 | 2.9 | GO:0001163 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.4 | 0.7 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.4 | 4.0 | GO:0034869 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.4 | 1.5 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.4 | 12.3 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.4 | 1.4 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.4 | 5.1 | GO:0032183 | SUMO binding(GO:0032183) |
0.4 | 1.1 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.4 | 2.9 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.4 | 1.4 | GO:0043559 | insulin binding(GO:0043559) |
0.4 | 2.2 | GO:0015288 | porin activity(GO:0015288) |
0.4 | 12.1 | GO:0030145 | manganese ion binding(GO:0030145) |
0.4 | 1.4 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.4 | 3.2 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.4 | 3.9 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.4 | 1.1 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.4 | 3.5 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.4 | 3.9 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.4 | 1.8 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.4 | 6.0 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.4 | 1.1 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.3 | 1.0 | GO:0008026 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.3 | 7.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.3 | 2.0 | GO:0030274 | LIM domain binding(GO:0030274) |
0.3 | 3.8 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.3 | 0.3 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.3 | 1.4 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.3 | 4.7 | GO:0010181 | FMN binding(GO:0010181) |
0.3 | 3.0 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.3 | 1.0 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.3 | 4.7 | GO:0005521 | lamin binding(GO:0005521) |
0.3 | 6.7 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.3 | 6.7 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.3 | 0.7 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.3 | 1.0 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.3 | 1.0 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.3 | 1.0 | GO:0030519 | snoRNP binding(GO:0030519) |
0.3 | 0.7 | GO:0030911 | TPR domain binding(GO:0030911) |
0.3 | 1.0 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.3 | 13.4 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.3 | 1.0 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.3 | 1.0 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.3 | 1.0 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.3 | 2.9 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.3 | 0.6 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.3 | 1.3 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.3 | 1.0 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.3 | 1.0 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.3 | 0.6 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.3 | 3.5 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.3 | 1.6 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.3 | 2.8 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.3 | 3.5 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.3 | 8.1 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.3 | 2.2 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.3 | 2.2 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.3 | 0.9 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.3 | 0.9 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.3 | 0.9 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.3 | 0.3 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.3 | 2.7 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.3 | 0.9 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.3 | 0.6 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.3 | 4.2 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.3 | 1.2 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.3 | 6.0 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.3 | 2.1 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.3 | 1.5 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.3 | 2.7 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.3 | 1.2 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.3 | 5.9 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.3 | 2.0 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.3 | 2.0 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.3 | 1.7 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.3 | 0.3 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.3 | 2.0 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.3 | 2.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.3 | 4.0 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.3 | 0.6 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.3 | 4.8 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.3 | 1.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.3 | 0.6 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.3 | 1.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.3 | 2.8 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.3 | 0.8 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.3 | 2.3 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.3 | 2.2 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.3 | 0.8 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.3 | 0.8 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.3 | 1.1 | GO:0043426 | MRF binding(GO:0043426) |
0.3 | 0.3 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.3 | 1.1 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.3 | 0.8 | GO:0019002 | GMP binding(GO:0019002) |
0.3 | 47.5 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.3 | 0.3 | GO:0036222 | dITP diphosphatase activity(GO:0035870) XTP diphosphatase activity(GO:0036222) |
0.3 | 2.1 | GO:0015266 | protein channel activity(GO:0015266) |
0.3 | 1.3 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.3 | 7.4 | GO:0050699 | WW domain binding(GO:0050699) |
0.3 | 3.4 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.3 | 0.5 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.3 | 2.4 | GO:0034918 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.3 | 0.8 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.3 | 4.0 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.3 | 0.5 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.3 | 2.9 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.3 | 0.3 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.3 | 1.6 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.3 | 13.9 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.3 | 6.5 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.3 | 1.8 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.3 | 2.1 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.3 | 1.6 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.3 | 2.3 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.3 | 0.8 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.3 | 6.5 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.3 | 0.8 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.3 | 0.5 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.3 | 1.0 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.3 | 2.8 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.3 | 1.3 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.3 | 1.0 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.3 | 0.5 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.3 | 4.6 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.3 | 3.6 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.3 | 0.8 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.3 | 9.4 | GO:0005507 | copper ion binding(GO:0005507) |
0.3 | 0.8 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.3 | 1.8 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.3 | 0.3 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.3 | 2.0 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.2 | 1.0 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.2 | 2.2 | GO:0005123 | death receptor binding(GO:0005123) |
0.2 | 1.2 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.2 | 1.5 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.2 | 0.5 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.2 | 1.2 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.2 | 2.0 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.2 | 0.5 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.2 | 2.0 | GO:0043733 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.2 | 0.5 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.2 | 1.5 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.2 | 2.5 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.2 | 0.7 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 1.0 | GO:0071253 | connexin binding(GO:0071253) |
0.2 | 1.7 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.2 | 1.4 | GO:0008469 | histone-arginine N-methyltransferase activity(GO:0008469) |
0.2 | 1.0 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.2 | 0.5 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.2 | 0.2 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.2 | 0.5 | GO:0045340 | mercury ion binding(GO:0045340) |
0.2 | 0.9 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.2 | 1.4 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.2 | 0.5 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.2 | 4.2 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 0.5 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.2 | 8.8 | GO:0008565 | protein transporter activity(GO:0008565) |
0.2 | 1.2 | GO:0070513 | death domain binding(GO:0070513) |
0.2 | 0.7 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.2 | 0.9 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.2 | 0.2 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.2 | 4.3 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.2 | 8.7 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.2 | 1.6 | GO:0000150 | recombinase activity(GO:0000150) |
0.2 | 0.9 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.2 | 5.7 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.2 | 0.7 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.2 | 5.4 | GO:0042805 | actinin binding(GO:0042805) |
0.2 | 0.9 | GO:0005113 | patched binding(GO:0005113) |
0.2 | 4.1 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.2 | 1.8 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.2 | 0.2 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.2 | 0.9 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.2 | 0.9 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.2 | 7.0 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.2 | 10.5 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.2 | 1.3 | GO:0050733 | RS domain binding(GO:0050733) |
0.2 | 0.7 | GO:0004359 | glutaminase activity(GO:0004359) |
0.2 | 0.7 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.2 | 5.5 | GO:0000907 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.2 | 1.3 | GO:0045545 | syndecan binding(GO:0045545) |
0.2 | 0.9 | GO:0005536 | glucose binding(GO:0005536) |
0.2 | 1.3 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.2 | 2.8 | GO:0015928 | fucosidase activity(GO:0015928) |
0.2 | 2.4 | GO:0043531 | ADP binding(GO:0043531) |
0.2 | 5.3 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.2 | 0.4 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.2 | 0.2 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.2 | 4.5 | GO:0005537 | mannose binding(GO:0005537) |
0.2 | 0.2 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.2 | 0.8 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.2 | 6.6 | GO:0019843 | rRNA binding(GO:0019843) |
0.2 | 12.2 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.2 | 0.8 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.2 | 2.1 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.2 | 0.8 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.2 | 1.0 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.2 | 0.6 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.2 | 0.6 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.2 | 6.6 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.2 | 0.6 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.2 | 1.4 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.2 | 1.0 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.2 | 0.2 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.2 | 0.4 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.2 | 3.8 | GO:0000049 | tRNA binding(GO:0000049) |
0.2 | 1.8 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.2 | 0.8 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.2 | 1.0 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.2 | 1.2 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.2 | 7.1 | GO:0016875 | ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.2 | 0.8 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.2 | 0.2 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.2 | 0.8 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.2 | 0.8 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.2 | 1.2 | GO:0031491 | nucleosome binding(GO:0031491) |
0.2 | 5.8 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.2 | 1.6 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.2 | 0.4 | GO:0000339 | RNA cap binding(GO:0000339) |
0.2 | 0.8 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.2 | 2.5 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.2 | 1.1 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.2 | 1.5 | GO:0051400 | BH domain binding(GO:0051400) |
0.2 | 0.9 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.2 | 3.0 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.2 | 0.8 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.2 | 0.6 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.2 | 0.8 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.2 | 0.2 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.2 | 0.6 | GO:0031013 | troponin I binding(GO:0031013) |
0.2 | 0.6 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.2 | 0.4 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.2 | 2.4 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.2 | 1.5 | GO:0043274 | phospholipase binding(GO:0043274) |
0.2 | 2.6 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.2 | 0.7 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.2 | 2.9 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.2 | 0.9 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.2 | 2.4 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.2 | 6.0 | GO:0035064 | methylated histone binding(GO:0035064) |
0.2 | 0.7 | GO:0034603 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.2 | 3.2 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.2 | 0.7 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.2 | 4.3 | GO:0051287 | NAD binding(GO:0051287) |
0.2 | 3.5 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.2 | 0.2 | GO:0031014 | troponin T binding(GO:0031014) |
0.2 | 6.1 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.2 | 0.7 | GO:0004532 | exoribonuclease activity(GO:0004532) |
0.2 | 0.9 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.2 | 3.3 | GO:0017022 | myosin binding(GO:0017022) |
0.2 | 1.9 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.2 | 5.4 | GO:0051087 | chaperone binding(GO:0051087) |
0.2 | 1.2 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.2 | 3.8 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.2 | 0.7 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.2 | 3.1 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.2 | 0.3 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.2 | 0.2 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.2 | 3.3 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.2 | 0.5 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.2 | 9.5 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.2 | 1.5 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.2 | 1.4 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.2 | 0.5 | GO:0031432 | titin binding(GO:0031432) |
0.2 | 1.7 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.2 | 3.7 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.2 | 1.2 | GO:0015250 | water channel activity(GO:0015250) |
0.2 | 0.2 | GO:0001846 | opsonin binding(GO:0001846) |
0.2 | 1.8 | GO:0001618 | virus receptor activity(GO:0001618) |
0.2 | 3.5 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.2 | 0.5 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.2 | 1.5 | GO:0030955 | potassium ion binding(GO:0030955) |
0.2 | 0.5 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.2 | 0.5 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.2 | 0.5 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.2 | 0.3 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.2 | 2.0 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.2 | 3.8 | GO:0019209 | kinase activator activity(GO:0019209) |
0.2 | 0.3 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.2 | 0.2 | GO:0034062 | RNA polymerase activity(GO:0034062) |
0.2 | 0.3 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.2 | 0.2 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.2 | 0.8 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.2 | 1.0 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.2 | 1.9 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.2 | 0.2 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.2 | 0.9 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.2 | 0.5 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.2 | 1.9 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.2 | 24.4 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.2 | 0.5 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.2 | 0.5 | GO:0015232 | heme transporter activity(GO:0015232) |
0.2 | 0.5 | GO:0022884 | macromolecule transmembrane transporter activity(GO:0022884) |
0.2 | 0.3 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.2 | 1.1 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.2 | 0.9 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.2 | 0.9 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.2 | 0.6 | GO:0005542 | folic acid binding(GO:0005542) |
0.2 | 0.2 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.1 | 0.7 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.1 | 0.6 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.1 | 16.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.4 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 2.1 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 0.9 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 2.9 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.4 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 4.0 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.1 | 0.6 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 0.3 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 0.3 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.1 | 0.3 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 4.3 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 3.1 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 0.4 | GO:0070061 | fructose binding(GO:0070061) |
0.1 | 3.1 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.4 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.1 | 1.8 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 0.5 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 1.6 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 1.2 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 6.0 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 6.0 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
0.1 | 0.7 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.1 | 4.0 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) cis-trans isomerase activity(GO:0016859) |
0.1 | 0.7 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 0.4 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 1.0 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 1.0 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 0.3 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.1 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 2.4 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 0.9 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 0.1 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.1 | 4.1 | GO:0004866 | endopeptidase inhibitor activity(GO:0004866) |
0.1 | 0.1 | GO:0019239 | deaminase activity(GO:0019239) |
0.1 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.6 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.7 | GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups(GO:0016725) |
0.1 | 1.5 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.2 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.1 | 1.7 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.1 | 0.5 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.1 | 0.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.1 | 3.1 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.1 | 2.8 | GO:0008748 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) epoxyqueuosine reductase activity(GO:0052693) |
0.1 | 1.7 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.1 | 0.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.1 | 0.4 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.1 | 1.1 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 5.2 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.1 | 0.1 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 0.2 | GO:2001069 | glycogen binding(GO:2001069) |
0.1 | 0.3 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.1 | 0.2 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.1 | 0.9 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 0.5 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 2.1 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 4.6 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 1.3 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.1 | 0.2 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.1 | 1.1 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 0.2 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.1 | 0.3 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.1 | 10.3 | GO:0001047 | core promoter binding(GO:0001047) |
0.1 | 1.7 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 2.5 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 0.3 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.4 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.1 | 0.5 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 0.4 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.1 | 0.4 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 1.6 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.1 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 0.3 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.3 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.8 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 0.8 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 0.6 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 10.4 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 2.5 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 0.3 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 0.2 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
0.1 | 0.1 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.1 | 0.1 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 0.3 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.1 | 0.4 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.1 | 0.1 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.1 | 1.2 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.1 | 0.4 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 0.4 | GO:0016936 | galactoside binding(GO:0016936) |
0.1 | 1.0 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 0.3 | GO:1990405 | protein antigen binding(GO:1990405) |
0.1 | 1.0 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 0.3 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.1 | 0.3 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.1 | 0.1 | GO:0051184 | cofactor transporter activity(GO:0051184) |
0.1 | 0.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 0.1 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.1 | 1.1 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.2 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.1 | 2.7 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.1 | 0.1 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.1 | 0.6 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 5.5 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 0.3 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 0.3 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 3.1 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.1 | 0.2 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.1 | 0.3 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.1 | 0.5 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 1.0 | GO:0004386 | helicase activity(GO:0004386) |
0.1 | 0.2 | GO:0055100 | adiponectin binding(GO:0055100) |
0.1 | 0.3 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.1 | 1.8 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.3 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.1 | 0.6 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.1 | 0.3 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 0.3 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.3 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.1 | 0.4 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.1 | 0.2 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 1.9 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.1 | 0.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 0.6 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.2 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 0.1 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.1 | 0.3 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 0.3 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.8 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.1 | 0.3 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 4.5 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.1 | 0.2 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 0.3 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 0.4 | GO:0019956 | chemokine binding(GO:0019956) |
0.1 | 16.2 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.1 | 0.6 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 0.1 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 0.1 | GO:0031404 | chloride ion binding(GO:0031404) |
0.1 | 1.6 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 0.3 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 1.8 | GO:0015296 | anion:cation symporter activity(GO:0015296) |
0.1 | 0.2 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 0.1 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.1 | 1.3 | GO:0016893 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters(GO:0016893) |
0.1 | 0.5 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 0.1 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.1 | 0.2 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 0.5 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 0.9 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.3 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.1 | 0.2 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 0.2 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.1 | 0.5 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.1 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 0.6 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.1 | 0.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.3 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 0.2 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.1 | 1.2 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 0.1 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 10.3 | GO:0019901 | protein kinase binding(GO:0019901) |
0.1 | 0.1 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.1 | 0.1 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 6.3 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 0.8 | GO:0043236 | laminin binding(GO:0043236) |
0.1 | 0.5 | GO:0016684 | peroxidase activity(GO:0004601) oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.1 | 0.2 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 0.1 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 2.1 | GO:0008527 | taste receptor activity(GO:0008527) |
0.1 | 1.7 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.1 | 0.2 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 1.9 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.1 | 1.5 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.1 | 0.5 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 24.5 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.1 | 0.2 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 0.1 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 0.1 | GO:0035473 | lipase binding(GO:0035473) |
0.0 | 1.5 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.0 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.1 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.0 | 0.0 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.0 | 0.0 | GO:0038132 | neuregulin binding(GO:0038132) |
0.0 | 0.1 | GO:0015925 | galactosidase activity(GO:0015925) |
0.0 | 0.1 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.0 | 0.2 | GO:0009055 | electron carrier activity(GO:0009055) |
0.0 | 0.1 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.0 | 0.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.0 | 4.1 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.0 | 0.4 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.0 | 0.4 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.4 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.0 | 0.3 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.0 | 0.1 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.0 | 0.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.0 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.1 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.0 | 0.1 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.0 | 0.6 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 0.0 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) |
0.0 | 0.2 | GO:0016502 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.0 | 0.2 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.0 | 0.2 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.0 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 0.1 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 3.3 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.1 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.0 | 0.0 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.0 | 0.5 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.0 | 3.1 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.0 | 0.0 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.0 | 0.1 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.0 | 3.1 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.0 | 0.1 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.0 | 0.1 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.0 | 0.1 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.1 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 0.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 0.1 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.0 | 0.1 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 0.2 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 1.3 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.1 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.0 | 0.0 | GO:0051540 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.0 | 0.0 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.0 | 0.1 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.4 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.0 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.1 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.0 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.0 | 0.1 | GO:0008933 | lytic transglycosylase activity(GO:0008933) |
0.0 | 0.1 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.0 | 0.1 | GO:0042731 | PH domain binding(GO:0042731) |
0.0 | 0.2 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.0 | 0.0 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.0 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.0 | 0.0 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.0 | 1.5 | GO:0016887 | ATPase activity(GO:0016887) |
0.0 | 0.0 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.0 | 2.6 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.0 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.0 | 0.1 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.0 | 0.0 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.0 | 2.2 | GO:0004175 | endopeptidase activity(GO:0004175) |
0.0 | 0.0 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.0 | 0.0 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 0.0 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.0 | 0.2 | GO:0032561 | guanyl ribonucleotide binding(GO:0032561) |
0.0 | 0.5 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.0 | 0.3 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.0 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.0 | 0.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.1 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.0 | 0.1 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.0 | 0.0 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.0 | 11.2 | GO:0004984 | olfactory receptor activity(GO:0004984) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 2.5 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.9 | 1.8 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.9 | 15.1 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.7 | 17.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.7 | 5.9 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.7 | 9.5 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.7 | 7.3 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.6 | 0.6 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.6 | 26.3 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.6 | 8.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.6 | 19.2 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.6 | 1.1 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.5 | 5.4 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.5 | 21.4 | PID PLK1 PATHWAY | PLK1 signaling events |
0.5 | 0.5 | ST GAQ PATHWAY | G alpha q Pathway |
0.5 | 2.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.5 | 1.6 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.5 | 12.6 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.5 | 2.9 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.5 | 3.7 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.4 | 10.6 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.4 | 3.1 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.4 | 7.0 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.4 | 21.2 | PID E2F PATHWAY | E2F transcription factor network |
0.4 | 11.6 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.4 | 6.2 | PID ATM PATHWAY | ATM pathway |
0.4 | 5.3 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.4 | 14.0 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.4 | 10.7 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.4 | 1.6 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.4 | 7.9 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.4 | 3.5 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.4 | 1.5 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.4 | 5.7 | PID ARF 3PATHWAY | Arf1 pathway |
0.4 | 13.3 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.4 | 5.3 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.4 | 1.1 | PID IGF1 PATHWAY | IGF1 pathway |
0.4 | 12.6 | PID LKB1 PATHWAY | LKB1 signaling events |
0.4 | 0.4 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.4 | 9.8 | PID RHOA PATHWAY | RhoA signaling pathway |
0.4 | 1.8 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.4 | 12.9 | PID P53 REGULATION PATHWAY | p53 pathway |
0.4 | 8.6 | PID ATR PATHWAY | ATR signaling pathway |
0.3 | 5.8 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.3 | 3.7 | PID AURORA A PATHWAY | Aurora A signaling |
0.3 | 1.3 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.3 | 11.9 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.3 | 1.3 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.3 | 5.6 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.3 | 13.5 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.3 | 0.6 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.3 | 4.8 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.3 | 1.6 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.3 | 0.5 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.3 | 3.0 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.3 | 5.7 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.3 | 12.7 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.3 | 12.1 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.3 | 4.6 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.3 | 1.8 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.3 | 6.3 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 5.6 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.2 | 3.6 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.2 | 1.0 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.2 | 2.3 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.2 | 4.9 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.2 | 1.6 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 1.6 | PID EPO PATHWAY | EPO signaling pathway |
0.2 | 3.9 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.2 | 4.0 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.2 | 1.0 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.2 | 1.9 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.2 | 2.0 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 4.7 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.2 | 2.1 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.2 | 0.6 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.2 | 5.9 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.2 | 0.7 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.2 | 1.3 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.2 | 0.4 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 1.0 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.2 | 4.9 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.2 | 3.5 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.2 | 1.3 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.2 | 1.3 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.2 | 0.2 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.2 | 3.4 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.2 | 2.0 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 1.2 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 1.5 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 5.1 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 4.4 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 0.9 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 1.1 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 1.7 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 0.6 | ST ADRENERGIC | Adrenergic Pathway |
0.1 | 1.9 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 0.8 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 0.5 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 1.2 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 2.2 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 0.7 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 0.7 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 0.4 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 0.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 17.9 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 0.2 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 0.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 1.4 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 0.8 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 0.2 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 1.2 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.5 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 0.1 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 0.6 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 1.1 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 0.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 0.5 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 1.2 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 0.2 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.5 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.5 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.3 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.0 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.2 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.4 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.1 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 1.4 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.4 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.6 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.3 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.0 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 1.9 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
1.4 | 24.5 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
1.3 | 18.5 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
1.1 | 12.8 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
1.0 | 17.7 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
1.0 | 16.2 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.9 | 7.2 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.9 | 11.2 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.9 | 7.8 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.8 | 10.7 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.8 | 13.0 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.8 | 8.1 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.8 | 7.0 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.8 | 7.7 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.8 | 6.1 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.7 | 7.4 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.7 | 7.3 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.7 | 6.4 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.7 | 3.4 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.6 | 6.3 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.6 | 5.5 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.6 | 4.8 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.6 | 1.8 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.6 | 0.6 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.6 | 0.6 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.6 | 4.7 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.6 | 4.1 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.6 | 1.2 | REACTOME MITOTIC G1 G1 S PHASES | Genes involved in Mitotic G1-G1/S phases |
0.6 | 10.2 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.6 | 13.0 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.5 | 11.3 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.5 | 13.9 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.5 | 4.8 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.5 | 0.5 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.5 | 3.2 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.5 | 8.9 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.5 | 3.1 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.5 | 6.3 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.5 | 9.8 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.5 | 5.1 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.5 | 3.1 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.5 | 5.0 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.5 | 3.0 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.5 | 13.3 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.5 | 5.4 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.5 | 2.5 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.5 | 2.4 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.5 | 35.0 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.5 | 14.2 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.5 | 3.7 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.5 | 7.7 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.5 | 5.9 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.4 | 4.9 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.4 | 3.1 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.4 | 7.2 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.4 | 4.3 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.4 | 4.7 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.4 | 9.8 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.4 | 3.4 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.4 | 2.9 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.4 | 36.7 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.4 | 0.4 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.4 | 12.3 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.4 | 1.2 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.4 | 0.4 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.4 | 5.5 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.4 | 23.7 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.4 | 11.2 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.4 | 8.4 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.4 | 3.0 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.4 | 0.4 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.4 | 4.2 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.4 | 3.8 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.4 | 1.9 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.4 | 3.4 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.4 | 8.2 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.4 | 6.6 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.4 | 5.1 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.4 | 34.0 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.4 | 3.9 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.3 | 2.1 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.3 | 5.2 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.3 | 1.4 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.3 | 2.7 | REACTOME OPSINS | Genes involved in Opsins |
0.3 | 1.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.3 | 4.2 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.3 | 2.3 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.3 | 14.2 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.3 | 6.4 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.3 | 3.2 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.3 | 4.1 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.3 | 2.5 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.3 | 1.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.3 | 0.3 | REACTOME PLATELET HOMEOSTASIS | Genes involved in Platelet homeostasis |
0.3 | 3.7 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.3 | 4.3 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.3 | 8.9 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.3 | 2.7 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.3 | 3.3 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.3 | 4.4 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.3 | 2.3 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.3 | 7.6 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.3 | 4.1 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.3 | 9.0 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.3 | 4.0 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.3 | 4.3 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.3 | 3.1 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.3 | 4.5 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.3 | 2.2 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.3 | 2.8 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.3 | 7.8 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.3 | 3.0 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.3 | 2.3 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.3 | 1.0 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.3 | 2.0 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.3 | 6.5 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.3 | 5.8 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.2 | 2.0 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.2 | 1.7 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.2 | 1.9 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.2 | 3.5 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.2 | 2.5 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.2 | 1.8 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 8.2 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.2 | 13.5 | REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | Genes involved in The citric acid (TCA) cycle and respiratory electron transport |
0.2 | 5.7 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.2 | 3.7 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.2 | 1.5 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.2 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.2 | 0.4 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.2 | 0.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.2 | 4.0 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.2 | 0.6 | REACTOME S PHASE | Genes involved in S Phase |
0.2 | 4.5 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.2 | 0.2 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.2 | 0.6 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.2 | 2.2 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.2 | 4.2 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.2 | 0.4 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.2 | 4.9 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.2 | 17.1 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.2 | 0.8 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.2 | 0.8 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.2 | 2.3 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.2 | 2.1 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.2 | 1.5 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.2 | 0.9 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.2 | 1.5 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.2 | 16.8 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.2 | 15.1 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.2 | 1.8 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.2 | 2.3 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.2 | 0.9 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.2 | 0.2 | REACTOME DNA REPLICATION | Genes involved in DNA Replication |
0.2 | 2.4 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.2 | 3.3 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.2 | 0.7 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.2 | 0.9 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.2 | 1.0 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.2 | 1.2 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.2 | 0.8 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.2 | 2.9 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.2 | 1.7 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.2 | 19.1 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.2 | 6.7 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.2 | 2.0 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.2 | 1.5 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.2 | 1.8 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.2 | 0.2 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.2 | 0.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.2 | 1.7 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.2 | 4.0 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.1 | 4.8 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.1 | 4.4 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 2.5 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.1 | 2.0 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 0.4 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 6.0 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 2.5 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 0.4 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.1 | 3.4 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 1.1 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 1.6 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.1 | 0.9 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 0.4 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 1.1 | REACTOME METABOLISM OF RNA | Genes involved in Metabolism of RNA |
0.1 | 1.2 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 2.5 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.1 | 0.6 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.1 | 1.9 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 7.1 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 0.6 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 3.8 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.1 | 0.5 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 2.3 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.1 | 0.4 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 0.9 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 0.8 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 0.1 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.1 | 0.3 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 0.5 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.1 | 0.2 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.1 | 0.5 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 0.6 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.1 | 0.4 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 1.5 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 0.8 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.1 | 0.5 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 0.1 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 1.9 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.1 | 0.9 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 0.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 1.9 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 0.4 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.1 | 1.0 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 0.1 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 0.9 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 0.4 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 0.2 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 2.0 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.1 | 0.1 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.1 | 0.5 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 0.2 | REACTOME DEFENSINS | Genes involved in Defensins |
0.1 | 0.3 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.0 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.0 | 0.1 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.1 | REACTOME HEMOSTASIS | Genes involved in Hemostasis |
0.0 | 0.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.0 | 0.1 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.4 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.0 | 0.1 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.0 | 0.4 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.1 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.0 | 0.0 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.0 | 0.1 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 0.3 | REACTOME TRANSLATION | Genes involved in Translation |
0.0 | 0.8 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.0 | 0.5 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.7 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |